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Abstract 
Background: Sexually transmitted infection, including HIV, is a significant public health 
concern, associated with sexual risk-taking (SRT). Negative affective states, such as 
anxiety and depression have been highlighted as factors influencing engagement in SRT. 
However, the literature provides mixed evidence as to the existence, and direction of an 
association between negative affect and SRT. Currently, no narrative synthesis of the 
evidence base has been identified. 
Aims: The review aimed to systematically explore the methodological quality of, and 
evaluate the evidence pertaining to, a relationship between negative affect (both anxiety 
and depression) and SRT behaviour. In addition, the measures of anxiety, depression and 
SRT employed have been reviewed. 
Methods: A pre-defined keyword strategy was used to search 4 databases for studies 
published between 1995 and 2015. Following screening of 111 abstracts, 9 studies were 
identified as fulfilling the eligibility criteria. The STROBE checklist was used to guide 
quality assessment for each of the included studies. 
Results: Overall, there was a positive relationship identified between anxiety and 
depression, with SRT, however this was dependent upon the operationalised definition of 
SRT used. In addition, methodological issues relating to the temporal coverage of 
measures and highly specific samples highlight the need to interpret findings with caution. 
Conclusions: There appears to be tentative evidence indicating an association between 
anxiety and depression with SRT in the articles under review in this study. Future research 
must, however, expand beyond cross-sectional design, toward longitudinal analysis, which 
will enable delineation of the processes underpinning this possible association. 
 
Key words: sexual risk-taking, anxiety, depression, evidence review 
 11 
Introduction 
Sexual risk-taking (SRT) behaviour is a significant public health concern due to the 
resultant outcomes of unintended pregnancy and sexually transmitted infection (STI), 
which can have a profound impact on sexual, reproductive and overall health and 
wellbeing (WHO, 2015). While definitions of SRT vary considerably and continue to 
evolve, it has been stated that “it is difficult to gather a precise definition of when sexual 
behavior is risky… a helpful working hypothesis… for risky sexual behavior is associated 
with undesirable outcome” (Sherr, 2007 p.194). Within the sexual health literature SRT 
has often been narrowly defined and typically focused on individual sexual practices such 
as multiple sexual partners and non-condom use (e.g., Noar, Cole, & Carlyle, 2006) that 
place the individual at high risk for directly contracting a STI, including HIV. However, 
broader conceptualisations of SRT have emerged to include age at first sex before the age 
of 16 years, previous STI diagnosis (Sonkin et al., 2007), number of one-night-stands 
(Bancroft et al., 2007), exchanging sex for money (e.g. Roberts et al., 2003), and engaging 
in sexual acts under the influence of alcohol and/or drugs (e.g. Camacho, Brown, & 
Simpson, 1996). Moreover, in addition to the individual’s behaviour, SRT can be defined 
according to the nature of the partner, for example, engaging in sexual practices with HIV-
positive, intravenous drug using, and non-monogamous, sexual partners. Although these 
broad conceptualisations may not relate to an individual’s high risk of directly acquiring a 
STI (i.e. unprotected sex), they are associated with placing the individual at increased risk 
(Bancroft et al., 2007).  For the purposes of the current work, SRT is considered to include 
both the direct high-risk behaviours, and the higher-risk indirect behaviours indicated 
above. This broad definition of SRT is important to capture empirical behavioural 
indicators of SRT and has been recommended for use in epidemiological study worldwide 
(see Slaymaker, 2004).  
 The consequences of SRT can permeate beyond the individual risk-taker, affecting 
families, communities and wider society (Scottish Government, 2011).  For example, 
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mother-to-child transmission of STIs can result in stillbirth, neonatal death, sepsis, and 
pneumonia, and the Human Papilloma Virus infection causes 530,000 cases of cervical 
cancer worldwide each year (WHO, 2015). Thus, the modification of SRT is of paramount 
importance in preventing the spread of STIs (Downing-Jones, Cook, & Bellis, 2006). To 
address this issue researchers have attempted to identify factors that may lead individuals 
to engage in SRT behaviour.  One area of focus has been in relation to the association 
between SRT and common mental health disorders (e.g. Ramrakha et al., 2000; Roberts et 
al., 2003) 
 
Common Mental Health Disorders  
“Common mental health disorders” is an umbrella term used to include conditions such as 
depression, generalised anxiety disorder, panic disorder, social anxiety disorder, post-
traumatic stress disorder (PTSD) and obsessive compulsive disorder (OCD) (NICE, 2011). 
These disorders can affect a significant proportion of the population at any one time, with 
research demonstrating significant co-morbidity among the disorders (Singleton et al., 
2001). This co-morbidity suggests that the construct of common mental health disorders is 
a more valid and useful approach to conceptualising individual experiences of symptoms.  
For example, of the common mental health disorders a mix of symptoms of anxiety and 
depression is the most frequently occurring, with only a small proportion experiencing one 
without the other (Singleton et al., 2001). Although a number of studies have found an 
association between negative affective states and SRT in both adolescents and adults by 
assessing severity of psychiatric distress, few studies have found an association when using 
diagnostic assessments of psychiatric disorders (Remien, 2004) 
 
Anxiety and Depression in the Context of Sexual Risk-Taking Behaviour  
Symptoms of anxiety and depression differ considerably in severity, typically ranging in 
intensity from mild, moderate, to severe (American Psychiatric Association, (APA), 2013).  
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Many of the symptoms associated with common mental health disorders (e.g. low energy 
levels, fatigue, increased irritability, anxiety, and reduced interest and pleasure in 
previously enjoyed activities) may prohibit behavioural and social engagement and 
interaction (APA, 2013). Indeed, around 1 in 5 cases can become chronic and debilitating, 
negatively impacting upon routine daily activities and relationships, including sexual 
functioning (WHO, 2001).   
 It is commonly assumed that during elevated anxious and depressive states sexual libido 
(i.e. sexual desire and physiological arousal) is reduced (e.g. Beck, 1967; Kaplan, 1988; 
Figueira, et al., 2001; Ernst, Foldenyi & Angst, 1993).  An alternative hypothesis suggests 
that although many experiencing anxiety and depression have reduced sexual libido, there 
are a significant proportion of individuals with anxiety (Cranston-Cuebas & Barlow, 1990; 
Ware et al., 1996) and/or depression (Bancroft et al, 2004; Angst, 1998) that experience 
unchanged or increased sexual libido. Indeed, it has been suggested that a subjective 
experience of negative affect may be reduced by engaging in sexual behaviour, resulting in 
increased sexual desire (e.g. Bancroft et al., 2004). Thus, individuals may engage in sexual 
activity to increase a sense of self-worth, intimacy, and as a means to regulate and improve 
mood (e.g. Lykins, Janssen & Graham, 2006). Indeed, there is evidence suggesting that 
SRT increases in both anxiety and depression (e.g. Bancroft et al., 2004).  In depression at 
least, this may be related to an individual’s increased risk for suicidal ideation and self-
destructive behaviour, which may lead to disinhibition of sexual impulses. Individuals who 
do not care whether they live or die may come to the conclusion that there is no reason to 
warrant safe sex to avoid the risk of acquiring a STI (Remien, 2004). 
 A meta-analysis assessing the association between negative affective states (i.e. 
depression and anxiety [and anger]) and SRT reported little evidence of an association of 
any kind (neither positive nor negative; Crepaz & Marks, 2001). The authors found that 
effect sizes varied significantly across samples, and suggested that a number of potential 
moderating variables (e.g. operationalization of SRT, HIV status, studies with the strongest 
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methodological designs) may account for the variation observed. However, none of the 
variables identified significantly moderated associations that were found.   
 Furthermore, Crepaz and Marks (2001) identified a number of methodological and 
conceptual explanations for their outcome, which may have diminished the ability to detect 
significant associations (if present). First, even methodologically strong studies failed to 
measure negative affect and SRT over the same time frame (i.e. past week/month/year), 
thereby hampering opportunities to gain an accurate understanding of the temporal link 
between these factors. Secondly, the majority of the reviewed studies adopted statistical 
models that failed to account for the possibility that when anxious/depressive symptoms 
are severe, sexual libido may be greatly diminished, which can limit engagement in sexual 
activity; while in those individuals experiencing moderate anxious/depressive symptoms, 
sexual libido may be greatly increased, and may therefore be more likely to engage in 
SRT. Thirdly, it is suggested that the reviewed papers may not have accounted for all 
potential moderator variables (e.g. impulsivity, sexual desire) that could influence the 
association between negative affect and SRT.  It was recommended that future research 
should refine and re-develop conceptual and methodological practices.  
  
Aims and Objectives 
Given the co-morbid nature of anxiety and depression, it is important to focus on both 
these manifestations of common mental health disorders. Indeed, in the context of SRT the 
determination of the presence and direction of an association between anxiety and 
depression on the one hand, and SRT on the other, has important clinical and policy 
implications in terms of broadening conceptual understanding to inform prevention 
programmes (Bancroft et al., 2004; Semaan et al., 2002; Donohew, Palmgren & Lorch, 
1994). Thus, the review aims to critically appraise the evidence base in relation to the 
associations between both anxiety and depression, and SRT behaviour. In so doing, the 
following key questions are addressed: 
 15 
 
1. Are individuals experiencing symptoms of anxiety and/or depression 
more likely to engage in SRT than individuals with no symptoms of 
anxiety and/or depression? 
2. What measures of anxiety, depression, and SRT have been employed 
within the research literature? 
3. What are the methodological limitations of studies exploring the 
associations among anxiety, depression, and SRT? 
 
Method 
Search Strategy 
A number of different databases were searched in order to cover a wider range of relevant 
disciplines. EBSCO host was used to search CINAHL (nursing and allied health sciences) 
and PsychINFO (psychological and behavioural sciences) databases, and OVID was used 
to search EMBASE and MEDLINE (both medical science) databases. The search strategy 
included terms for the two key constructs: SRT behaviour, and anxiety and depression. The 
following is the search strategy as entered into Medline, including the use of database 
truncations (denoted by *) to search possible differences in endings in the terms: 
 
1. [SEX* RISK-TAKING] or [RISKY SEX]   
2. [DEPRESS*]  or [LOW MOOD] or [NEGATIVE MOOD] or [AFFECT] 
or [MENTAL HEALTH] or [COMMON MENTAL HEALTH 
DISORDER] or [ANXI*] or [STRESS*]  
3. 1. AND 2. 
  
 All searches were limited to those studies published in English language over the last 20 
years (1995-). The searches were undertaken on the 1
st
 July 2014 and updated in March 
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2015. Furthermore, as electronic database searches may not identify all relevant studies the 
reference lists of all included full text articles were manually reviewed for relevant articles. 
 
Eligibility Criteria  
The eligibility of studies was assessed according to a set of pre-specified inclusion and 
exclusion criteria (see Table 1).  
 
Table 1 
Eligibility criteria for including studies in the current review 
Inclusion criteria Exclusion criteria 
Studies that explore both depression and 
anxiety (as evident in co-morbidities in 
common mental health disorder) as a 
composite or individual score. 
Studies that employ measures of anxiety 
that are specific to particular types of 
anxiety disorders at listed in DSM-5 or 
ICD-10 (e.g. General Anxiety Disorder, 
Social Anxiety Disorder, PTSD, etc.). 
  
Studies investigating any form of sexual 
risk-taking behaviour, as it has been 
operationalized in many different ways. 
Studies of adult or child sexual abuse.  
 
Studies not published in English. 
  
Observational study designs (cohort, case 
control, and cross-sectional) as these are 
most suited to investigating associations.  
 
Participants aged 16 years and above, 
which represents the age of sexual 
consent in the UK (among other 
countries). 
 
  
Data analysis could include primary or 
secondary quantitative data.  
 
 
Study Selection 
The study selection process has been in accordance with the PRISMA recommendations. 
Initially, all titles and abstracts were assessed for eligibility by the author and a second 
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rater, an academic researcher in public health. The full text of each of the remaining 
studies was screened by the author, and reasons for exclusion were noted. Disagreement 
between the raters arose relating to the title and abstracts of two studies, that both noted 
‘adolescents’ as the participant sample. It was unclear at this stage whether the adolescent 
sample included participants below the age of 16 years. This was addressed through 
discussion, resulting in the papers being included for full paper review. 
 
Data Extraction and Synthesis 
The following data were extracted for each eligible paper, as appropriate: author(s), year of 
publication, country of study, key sample characteristics (sampling strategy, number, age, 
and gender), study design, measure of anxiety, measure of depression, measure of SRT 
behaviour, and key findings. 
 Due to considerable heterogeneity in terms of study measures and outcomes, a meta-
analysis was considered to be a misleading approach, thus a narrative synthesis is reported. 
A narrative synthesis of the extracted data was conducted according to the themes 
addressed in the three research questions (i.e. nature of association, sample characteristics, 
measure of SRT, anxiety and depression). No quantitative meta-analysis was carried out.   
 
Quality Assessment 
A variety of tools (scales and checklists) exist for the critical appraisal of observational 
studies, which differ in terms of the study design(s) to which they relate (i.e. cross-
sectional, case-control, and/or cohort) their generic or subject-specific nature, and the 
criteria against which a study is appraised (see Sanderson et al. 2007). However, the 
Cochrane Collaboration openly discourages the use of scales and summary scores in 
favour of checklists (see Higgins & Green, 2011). 
 One of the most thorough checklists is the STrengthening Reporting of Observational 
studies in Epidemiology (STROBE) statement which was developed based on empirical 
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evidence and methodological/theoretical considerations and facilitates the critical appraisal 
of study design, conduct, and analysis (Vandenbroucke et al., 2007). The checklist 
comprises 22 items relating to each section of an article, with 18 items common across all 
three of the main study designs and four specific to each design (Vandenbroucke et al., 
2007; von Elm et al. 2007). The STROBE statement checklist (see Appendix II) was used 
to undertake a quality assessment of each of the eligible studies by the author and 
independent rater for increased reliability. The results of the quality assessment were 
presented for each STROBE item as "fulfilled" (meaning the paper addressed the item), 
"partially fulfilled" (meaning the item was partially addressed in the paper, or in the case of 
items with multiple parts, where not all parts have been addressed), or "unfulfilled" 
(meaning the paper did not address the item). 
 From a total of 198 items (22 items per study) the raters disagreed on three studies 
(Agardh et al., 2012; Bancroft et al., 2003; 2004). The sources of disagreement were 
focused on 7 items spread across 3 domains: Methods; Results; and Discussion. In two 
studies (Agardh et al., 2012; Bancroft et al., 2003) disagreement related to 3 items: item 12 
in the Methods domain (description and explanation of statistical methods); and items 13 
(reporting of rationale for and presentation of participants) and 14 (descriptive data of 
participants and possible confounders) in the Results domain. In the third study (Bancroft 
et al., 2004) disagreement was pertaining to item 20 (cautious overall interpretation of 
results covering objectives, limitations, analyses, and other evidence) from the Discussion 
domain. This equated to a 96% correspondence between the two reviewers following 
independent ratings of all 9 studies using the STROBE statement. Discrepancies between 
the raters were resolved through discussion, which resulted in a “partial fulfilment” 
categorisation for all of the items under discussion.  
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Results 
In total 116 articles were identified from database searches and manual screening of 
reference lists. Figure 1 shows the outcomes of each stage of screening for eligibility, 
which resulted in the inclusion of nine articles for analysis. A summary of each of the 
included studies can be found in Table 2, and are synthesised thereafter.  
 
 
Figure 1. PRISMA flow diagram of search strategy and results 
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Study Characteristics 
The nine studies were published between 1996 and 2011. A total of 5,285 participants 
were recruited across the studies with a median sample size for the studies of 589 (IQR: 
[Q3 (894.5) - Q1 (317)] = 577.5). Of the five studies that reported the mean age for 
participants, the median was 25.2 years (IQR: [Q3 (36.35)- Q1 (17.85)] = 18.5). The 
majority of studies were conducted in the USA (Bancroft et al, 2003; 2004; 2005, Roberts 
et al, 2003, Murphy et al, 2001, Marks et al., 1998, Camacho et al, 1996) with only one 
study conducted outside the USA in Uganda (Agardh et al, 2012). All of the studies 
employed surveys and seven were cross-sectional (Agardh et al, 2012; Turner et al., 2011; 
Bancroft et al, 2004; 2005, Roberts et al, 2003, Marks et al., 1998, Camacho et al, 1996), 
one was described as observational (Murphy et al, 2001), and one as matched-pairs 
(Bancroft et al., 2003). Moreover, five of the studies used primary data (Agardh et al, 
2012, Turner et al., 2011, Bancroft et al., 2003; 2004, Marks et al., 1998), two used 
secondary data (Bancroft et al., 2005 & Murphy et al, 2001), and the remaining studies 
conducted secondary analysis of primary data samples taken from intervention studies 
(Roberts et al, 2003 & Camacho et al, 1996). Moreover, two of the studies utilised the 
same dataset (Bancroft et al., 2003, 2005). 
 
Participant Sample Characteristics 
The study samples in the nine reviewed papers differed across various dimensions. First, 
samples differed in terms of their gender with four studies using both male and female 
participants (Agardh et al, 2012; Turner et al., 2011; Murphy et al, 2001; Camacho et al, 
1996), four studies using only male participants (Bancroft et al, 2003, 2004, 2005, Marks 
et al., 1998), and one study using only female participants (Roberts et al, 2003). Secondly, 
samples varied according to sexuality, with four studies using hetero-, homo- and, bi-
sexual participants (Agardh et al, 2012; Turner et al., 2011; Marks et al., 1998; Camacho et 
al, 1996), three studies using only homosexual participants (Bancroft et al., 2003, 2005; 
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Table 2  
Summary of included studies 
Study Sample Design Measure of 
anxiety 
Measure of 
depression 
Measure of SRT Results 
 
Agardh, 
et al. 
(2012) 
Uganda 
Convenience sample. 
Male and female 
Undergraduate 
students (N=980; 628  
<23 years , 329 >23 
years,  
23 missing age). 
Non-clinical sample. 
 
Cross-sectional 
design. 
Self-administered 
questionnaire. 
Primary data. 
 HSCL-25 
Anxiety 
items  
HSCL-25  
Depression 
items 
Bespoke measure:  
(i) Number of sexual partners in last 12 
months (≥2 coded as high and 1 as low)  
(ii) Condom use at last occasion of sexual 
intercourse (yes, no, and other dichotomised 
as consistent condom use and inconsistent 
condom use) 
 1. Positive association depression: 
(p<0.05) between number of sexual 
partners and depression (both males and 
females)  
2.  Positive association anxiety: (p<0.05) 
number of sexual partners and 
inconsistent condom use and anxiety 
(among males only). 
 
Turner   
et al. 
(2011) 
USA 
Convenience sample.  
Male and female 
African-American 
out-of-school youth 
(N= 680; 16-23 
years). 
Non-Clinical sample. 
 
Cross-sectional 
design.  
Audio computer-
assisted self-
interview. 
Primary data 
BAI  CES-D YRBSS sexual risk behaviour section. 
(i) Age of sexual debut 
(ii) Number of lifetime sexual partners  
(iii) Condom use at last sexual intercourse. 
1. Positive association anxiety: (p<0.01) 
lack of condom use and elevated anxiety 
symptoms.  
2. Positive association depression 
(p<0.01) number of lifetime sexual 
partners and depression symptoms 
Bancroft 
et al. 
(2005) 
USA 
Secondary data 
sample (taken from 
Bancroft et al, 2003) 
Homosexual males   
(HIV+ and HIV–; N= 
583; 18-67 years).  
Non-clinical sample  
 
Matched-pair 
design (taken 
from two sample 
sources across 
various sites) 
   STAI 
 
ZDPR Bespoke measure:  
(i) Frequency of unprotected anal intercourse 
(UAI) in the last 6 months as receptive 
partner, with someone whose serostatus is 
unknown  
(ii) Number of partners with whom UAI had 
occurred.  
Scores for 1. and 2. were combined for 
No significant main effects or 
interactions found across all analyses. 
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analysis 
 
Bancroft 
et al. 
(2004) 
USA 
Convenience sample. 
Heterosexual men 
(N=879; 18-81 
years). 
Mixed clinical/non-
clinical sample. 
 
Cross-sectional 
design.  
Self-administered 
questionnaire. 
Primary data. 
STAI ZDPR 1. One question from KISACUQ regarding 
HIV testing and serostatus, and past history of 
other STIs 
2. Three questions from DSHQ:  
(i). Number of different sexual partners in the 
past 12 months 
(ii) Number of sexual partners in last 3 years 
with whom no condoms used 
(iii) Number of one-night stands in lifetime 
 
1. Negative association depression 
(p<0.04): those with a propensity for 
depression reported fewer partners with 
whom no condoms were used than those 
with no depressive symptoms  
2. Positive association anxiety (p<0.018): 
those with anxiety reported an increased 
number of partners with whom no 
condoms had been used. (p<0.018)  
 
Bancroft 
et al. 
(2003) 
USA 
Convenience sample. 
Homosexual men (N 
= 589; 18-67 years). 
 Non-Clinical sample. 
 
Cross-sectional 
design.  
Self-administered 
questionnaire. 
Primary data. 
 STAI ZDPR Measured over last 6 months and over longer 
term: 1. Two questions from the original SOI, 
and one question from the revised SOI 
2. KISACUQ and DSQU were used to 
generate composite sores for 
(i) Anal intercourse  
(ii) Oral sex 
(iii) Casual sex 
(iv) Cruising 
(v) Information about HIV testing and 
serostatus and past history of other STIs  
 
1. No association across all depression 
analyses: recent SRT and anal 
intercourse (p=0.060ns); recent SRT and 
oral sex (B= 0.074ns); depression and 
no. of casual sex partners (B= -0.001ns); 
recent SRT and cruising (B=0.001ns)  
2. Negative association anxiety: recent 
SRT and anal intercourse (p=0.002); 
recent SRT and oral sex (p= 0.004)  
Roberts 
et al. 
(2003) 
USA 
African-American 
crack-abusing women 
(N=522; 18-52 years) 
Non-Clinical sample.  
Cross-sectional 
design. 
1-hour interview. 
Secondary 
analysis of 
primary data. 
 
DATAR 
Anxiety 
scale 
DATAR 
Depression 
scale 
 
RRBA  (in the last 30 days) 
(i) how many sexual partners,  
(ii) use of condoms,  
(iii) sex-trading behaviours (for drugs, money, 
food, shelter) 
1. Positive association depression 
(p<0.01): women with multiple partners 
reported higher levels of anxiety and 
depression. 
2. Positive association anxiety (p<0.01): 
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Murphy 
et al. 
(2001) 
USA 
HIV infected male 
and female 
adolescents  
Age 15+ 
Clinical Sample 
 
Observational 
study in 15 clinic 
sites (repeated 
measures). 
Secondary data. 
RCMAS  CES-D  Bespoke measure: (i) Number of sexual 
partners in the past 3 months (0 versus ≥1) 
(ii) condom use at most recent sexual 
intercourse (yes versus no). 
 
Positive association: 1. depression and 
unprotected sex at last intercourse.  
2. No association found with anxiety  
Marks   
et al. 
(1998) 
USA 
Convenience sample. 
HIV positive men 
(hetero-, homo-, bi-
sexual; N=155; 25- 
46+ years). 
Clinical Sample 
 
Cross-sectional 
design. 
Researcher-
administrated 
questionnaire. 
Primary data  
POMS. 
Tension-
Anxiety 
mood 
dimension  
POMS 
Depression-
Dejection 
mood 
dimension. 
Bespoke measure: most recent sexual 
encounter in the last 6 months  
(i) Type of partner (e.g. casual, anonymous, 
prostitute),  
(ii) HIV status of partner (HIV+  
or -),  
(iii) Use of alcohol or drugs by participant 
(yes or no) and partner (yes or no) 
(iv) Type of sex (e.g. receptive or insertive sex 
etc.) 
(v) Non-condom use in both anal and vaginal 
intercourse at last sexual intercourse 
 
Positive association depression and 
anxiety:  
1. unprotected anal intercourse, males 
only (p<0.05) (associations were 
consistent with HIV positive, HIV 
negative and unknown serostatus males). 
Camacho 
et al. 
(1996) 
USA 
Male and female 
opioid addicts 
(N=834; M=37 
years). 
Clinical Sample.  
Cross-sectional 
design using self-
administered 
questionnaire. 
Secondary 
analysis of 
primary data 
DATAR 
anxiety scale 
 
DATAR 
depression 
scale  
Bespoke measure: In the last 6 months 
1. number of sexual partners 
2. frequency of unprotected sex with (i) 
injection drug use (IDU) (ii) while intoxicated 
and (iii) trading sex 
1. Positive association depression and 
anxiety: number of sex partners 
(p<0.01); unprotected sex with IDU 
(P<0.05); unprotected sex while trading 
sex (p<0.05) 
Key: HSCL-25 = Hopkins symptom checklist-25 (Derogatis et al., 1974); DATAR = Drug Abuse Treatment for Aids-risk Reduction (Simpson, 1990); POMS = Profile of 
mood states questionnaire (McNair et al., 1981); CES-D = Center for Epidemiological Studies-Depression Scale (Radloff, 1977); STAI = Spielberger Trait Anxiety 
Inventory (Spielberger et al., 1970); ZDPR = Zemore Depression Proneness Ratings (Zemore et al., (1990); BAI = Beck Anxiety Inventory (Beck et al., 1988); RCMAS = 
Revised Manifest Anxiety Scale (Reynolds & Richmond, 1978); YRBSS = Youth Risk Behavior Surveillance; Survey (Centers for Disease Control and Prevention, 2004); 
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SOI= Sexual Orientation Inventory (and revised) (Simpson & Gangestad, 1991; Seal & Agostinelli, 1994); KISACUQ = Kinsey Institute Sexual Activity and Condom Use 
Questionnaire (Bancroft et al, 2003); DSHQ = Demographic and Sexual History Questionnaire (Bancroft et al., 2003); RBA=Revised Risk Behavioral Assessment 
(National Institute on Drug Abuse, 1991; Roberts et al., 2003) 
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Marks et al., 1998), and one study using only heterosexual participants (Bancroft et al., 
2004). Thirdly, samples varied according to clinical status with five studies using non-
clinical samples (Agardh et al, 2012; Turner et al., 2011; Roberts et al, 2003, Bancroft et 
al., 2003, 2005), four using clinical samples (Murphy et al, 2001, Marks et al., 1998; 
Camacho et al, 1996), with the remaining study using a mixed, clinical and non-clinical 
sample (Bancroft et al., 2004). Additional differentiation among samples included two 
studies that involved a drug-using sample (Roberts et al, 2003 & Camacho et al, 1996), 
two studies involved a HIV + sample (Murphy et al, 2001; Marks et al., 1998), one study 
involving a mixed, HIV+ and HIV- sample (Bancroft et al., 2005), one study involved an 
undergraduate student sample (Agardh et al., 2012), and one study involving a sample of 
unemployed youths not currently attending school, college, or university (Turner et al., 
2011). 
 
Measures of Sexual Risk Taking Behaviour 
A variety of tools were used to assess SRT.  Five studies used measures/questions 
developed for the purpose of the study (Agardh et al., 2012; Turner et al., 2011; Murphy et 
al, 2001; Marks et al., 1998; Camacho et al, 1996) and four studies used one or more pre-
existing measures/questions, including the Kinsey Institute Sexual Activity and Condom 
Use Questionnaire (KIACQ) (Bancroft et al., 2003, 2004) the Demographic and Sexual 
History Questionnaire (DSHQ) (Bancroft et al., 2003, 2004) the Sexual Risk Behavior 
section from the 2003 Youth Behavior Surveillance Survey (YRBSS) (Centers for Disease 
Control and Prevention, 2004) (Turner et al., 2011), and the NIDA-developed Risk 
Behavioral Assessment (RBA) instrument (Roberts et al., 2003). 
 Each of the nine studies included multiple measures of SRT, ranging from a minimum 
of two to a maximum of seven behaviours. All of the studies considered SRT as 
unprotected sex (either vaginal, anal, or both) as defined by non-condom use; however, 
there were differences in terms of when the risk behaviour took place.  For instance, five 
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studies measured ‘non-condom’ use at the last occasion of sexual intercourse, (Agardh et 
al., 2012; Turner et al., 2011; Murphy et al, 2001; Marks et al., 1998) with the remainder 
measuring the frequency of behaviour (i.e. how many incidents of unprotected sex) over a 
defined period of time (e.g. 6 months, 1 year, or 3 years) (Bancroft et al., 2003, 2004, 
2005; Roberts et al., 2003, Camacho et al, 1996 Eight studies also explored the ‘number of 
sexual partners’ as a SRT behaviour (excluding, Marks et al., 1998); however, the way in 
which this was operationally defined varied. For instance, six studies included number of 
sexual partners’ to cover both protected and unprotected sex (Agardh et al., 2012, Turner et 
al., 2011, Roberts et al., 2003, Murphy et al., 2001, Camacho et al., 1996), with the 
remaining three considering those ‘with whom no protection was used’ (Bancroft et al., 
2003, 2004, 2005).   
 In addition, each study set different temporal parameters when asking for the number of 
sexual partners.  Of those studies that included protected and unprotected sex, one 
considered the number of sexual partners within the past 12 months (Agardh et al., 2012), 
two, within the last 6 months (Murphy et al., 2001, Camacho et al., 1996), one within the 
last 30 days (Roberts et al., 2003), and one measured lifetime sexual partners (Turner et al., 
2011). Of the studies that considered unprotected sex only, three studies measured the 
number of sexual partners within the past 6 months (Bancroft et al., 2003, 2004, 2005), one 
within the last 12 months (Bancroft et al., 2003), three within the last 3 years (Bancroft et 
al., 2003; 2004), and two in a lifetime (Bancroft et al., 2003, 2004). The remaining 
measures of SRT were often specific to the study sample.  Five studies measured self-
report HIV status, self-directed HIV testing, and past history of STIs (Bancroft et al., 2003, 
2004, 2005; Murphy et al., 2001; Marks et al., 1998).  
 In addition, two studies also measured sex performed as a receptive partner, with 
someone whose HIV serostatus is unknown, and sex with casual partners (Bancroft et al., 
2003; Marks et al., 1998). Finally, two studies measured sex with injection drug-users, sex 
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whilst intoxicated, and trading for sex (i.e. prostitution) (Roberts et al, 2003; Camacho et 
al, 1996). 
 
Measures of Anxiety and Depression 
A variety of scales were used to measure anxiety and depression in the nine included 
studies. The most frequently used anxiety measure was the STAI, and most frequently used 
depression measure was the ZDPR (see Table 3). 
 
Table 3  
 Summary of anxiety and depression measures used in included studies 
Note: for abbreviations see key to Table 1. 
Scales                          Cut-off Studies  
For anxiety   
STAI Moderate 30 
Severe 45 
 
Bancroft et al. (2003; 2004; 2005) 
DATAR  
(anxiety scale) 
No recommendation 
 
Roberts et al. (2003), Camacho et al. (1996) 
BAI Minimal 0-7 
Mild 8-15 
Moderate 16-25 
Severe 26-63 
 
Turner et al. (2011) 
HSCL-25 1.75> caseness Agardh et al. (2012) 
RCMAS 19> caseness Murphy et al., (2001) 
POMS  
(tension-anxiety 
dimension) 
 
No recommendation Marks, et al. (1998) 
For depression   
ZDPR No recommendation Bancroft et al. (2003; 2004; 2005) 
DATAR  
(depressive scale) 
No recommendation 
 
Roberts et al. (2003), Camacho et al. (1996) 
HSCL-25 1.75> caseness 
 
Agardh et al. (2012) 
CES-D 16> symptomatic Turner et al. (2011), Murphy et al., (2001) 
POMS  
(depression-dejection 
dimension) 
No recommendation Marks, et al. (1998) 
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Nature of Association 
The review provides mixed evidence of an association between SRT and anxiety and 
depression. For instance, six studies found a positive association between anxiety and SRT 
(Agardh et al., 2012, p<0.05; Turner et al., 2011, p<0.01; Roberts et al., 2003, p<0.01; 
Marks et al., 1998, p<0.05; Camacho et al, 1996, p<0.01/p<0.05; Bancroft et al., 2004, 
p<0.018), whilst one found a negative association (Bancroft et al., 2003, p<0.002), and two 
found no association (Bancroft et al., 2005; Murphy et al., 2001, no p-values reported). 
Similarly, six studies found a positive association between depression and SRT (Agardh et 
al., 2012, p<0.05; Turner et al., 2011, p<0.01; Roberts et al., 2003, p<0.01; Murphy et al., 
2001, no p-value reported; Marks et al., 1998, p<0.05; Camacho et al, 1996, 
p<0.01/p<0.05), whilst one study found a negative association (Bancroft et al., 2004, 
p<0.04), and two found no association (Bancroft et al., 2003, p=0.06; 2005, no p-value 
reported). 
 
Quality Assessment 
The outcome of the quality assessment undertaken by the two assessors using the STROBE 
statement checklist is presented in Table 4. No one study fulfilled all items on the checklist 
with some variation across items that were fulfilled. The studies that fulfilled the most 
items on the checklist are Agardh et al., (2012), Turner et al., (2011) and Bancroft et al., 
(2005), while the study by Camacho et al. (1996) fulfilled the least. A small number of 
items were fulfilled by all studies (‘4’, presenting of key methods used early in paper; ‘8’, 
description of data sources and methods of measurement; and ‘15’, reported numbers of 
outcome events/summary measures) while items ‘1’ (appropriate and informative title and 
abstract), and ‘13’ (detailed participant reporting) were either unfulfilled or only partially 
fulfilled by all the studies. 
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Table 4  
Quality assessment of eligible studies 
  STROBE statement item 
Study  1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 
Agardh et al.     (2012) /                      / / /                
Turner et al.      (2011) /                    / /                 
Bancroft et al.   (2005) /   /                / /     /            
Bancroft et al.   (2004)                     / /          / /    
Bancroft et al.   (2003)                    / / /            
Roberts et al.,   (2003)                     /                
Murphy et al.    (2001) /       / /            /               
Marks et al.      (1998) /        / /        /  /               
Camacho et al. (1996)         / /           /                     
Fulfilled Unfulfilled / Partially fulfilled 
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Discussion 
Sexual risk-taking poses a considerable public health problem, and the modification of 
such behaviour is believed to be of paramount importance in the prevention of STIs 
(Downing-Jones et al, 2006). In particular, understanding the relationship between 
common mental health disorders, especially anxiety and depression, and SRT is believed 
to have important clinical and policy implications for modification of SRT and the 
prevention of STIs (Bancroft et al., 2004; Semaan et al., 2002; Donohew et. al., 1994). A 
variety of studies have explored the association between anxiety and depression, and SRT, 
however, a synthesis of these individual studies is required to give a global view of the 
evidence base. 
 This systematic review identified nine observational studies that explored the 
association between anxiety and depression, and SRT. The nature of the association 
between anxiety and depression and SRT differed across the nine studies. Five studies 
observed a positive association for both anxiety and depression with SRT (Agardh et al., 
2012; Turner et al., 2011; Roberts et al., 2003; Marks et al., 1998; Camacho et al, 1996) 
and one study found no association across all of the variables tested (Bancroft et al., 2005). 
In the remaining studies, one found a negative association with depression and a positive 
association with anxiety (Bancroft et al., 2004), one found a positive association with 
depression only (Murphy et al., 2001), and a negative association with anxiety only 
(Bancroft et al., 2003). The nature of the association in one study differed in terms of 
gender with a positive association with depression for males and females but only a 
positive association with anxiety for males not females (Agardh et al., 2012). Thus, this 
review supports the current evidence base indicating an association between anxiety, 
depression and SRT, and that a proportion of individuals (but by no means all) experience 
unchanged or increased subjective sexual desire during negative affective states (e.g. 
Bancroft et al., 2004; Ware et al., 1996).  
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 Traditionally, the association has been observed in terms of the negative impact of 
associated symptoms (e.g. low energy levels, fatigue, increased irritability, and reduced 
interest and pleasure in previously enjoyed activities; APA, 2013), and the documented 
side effects of anti-depressant/anxiety medications (e.g. Selective-Serotonin-Reuptake-
Inhibitors; Beta-Blockers) on routine daily activities and relationships, including sexual 
functioning (WHO, 2001). Relating to this issue of sexual functioning, difficulties with 
physiological sexual arousal (e.g. erectile dysfunction) may be a factor influencing sexual 
performance, which may affect the measurement of SRT outcomes. For example, an 
elevated subjective desire to engage in sexual activity may be offset or negatively affected 
by the ability to achieve or maintain an erection which may influence an individual’s 
decision to engage in sex at all, or indeed increase SRT behaviours in order to avoid 
certain situations (e.g. safe-sex practices such as condom negotiation with a partner) which 
may exacerbate such difficulties. 
 The presence of a positive association suggests that experiences of anxiety and 
depressive symptoms are linked to increased self-report of a variety of SRT behaviours. 
One explanation for this outcome is the idea that individuals may engage in SRT as a form 
of "self-medication" in order to reduce or minimise the experiences of negative affect (e.g. 
Bancroft et al., 2004). For instance, during sexual activity there is a release of endorphins 
(the body’s natural pain-killer), which produces an overall sense of well-being and 
increases feelings of security, peacefulness and self-worth (e.g. Legato, 2006; Lykins, 
Janssen & Graham, 2006). Moreover, during orgasm the release of the neurotransmitters 
oxytocin (in women) and vasopressin (in men) boost feelings of pleasure and a sense of 
intimacy, promoting partner bonding (Legato, 2012). However, this self-medication 
hypothesis requires further study to understand the potentially complex relationship 
between affect, sexual libido (i.e. both physiological arousal and subjective sexual desire) 
and SRT, and the factors that mediate and moderate these relationships. 
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Sample Characteristics 
The samples used in each of the reviewed studies varied widely in terms of gender (e.g. 
Marks et al, 1998; Roberts et al., 2003), age (e.g. Murphy et al., 2001; Turner et al., 2011), 
sexual orientation (Bancroft et al., 2004; Bancroft et al., 2005), and ethnic group (e.g. 
Rubin, Gold & Primack, 2009; Agardh et al, 2012). Across these highly specific samples 
there are likely to be a myriad of differences in terms of degrees of SRT. For example, in 
one study with a sample of undergraduate students with an age range of 16-23, SRT was 
classified as ‘high’ when a participant had 2 or more sexual partners within the past 12 
months, which does not warrant a classification of ‘high’ on a SRT measure (i.e. Agardh et 
al, 2012). Similarly, sample groups of injection (e.g. Roberts et al., 2011) may bias study 
outcomes because measures of SRT incorporate sex-trading (i.e. prostitution) and sex with 
injection drug-users which may be a risk more commonly encountered by this group 
relative to the general population. However, an increased focus on specific population 
samples as seen here may reflect an interest in addressing elevated risk in these groups.  
 Additionally, there may be factors to consider that are specific to particular population 
groups.  One study that sampled male only participants found that moderator variables 
accounted for the direction of association (i.e. Bancroft et al., 2003). For instance, the 
negative association found between anxiety and SRT pertained to the issue of 
physiological arousal. That is to say, sexual intercourse, which required a degree of 
physiological arousal, was negated by the effects of anxiety (Bancroft et al., 2003). 
Similarly, in HIV+ men there was evidence to suggest that possible condition-related 
erectile dysfunction impacted upon the ability to engage in sexual intercourse (Bancroft et 
al., 2005). This demonstrates that there are both between and within sample/group factors 
that may mediate the association between anxiety and depression and SRT, which justifies 
studying highly specific population groups. 
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Measures of Sexual-Risk Taking  
As previously noted, there is a link between sample characteristics and the way in which 
SRT is operationalised and measured. A variety of SRT measures were used across the 
nine studies. For instance, in studies that sampled from highly specific groups-measures 
incorporating sex that had taken place with injection drug-users (e.g. Roberts et al., 2011), 
anal sex with HIV + and HIV – males (e.g. Marks et al., 1998), and trading sex for drugs, 
money, food, and shelter (e.g. Camacho et al., 1996).   Moreover, even types of SRT that 
were used in all studies (i.e. unprotected sex) were operationalised and measured in 
different ways. The use of multiple definitions, and in some instances, the creation of 
composite scores has identified that associations may exist with specific behaviours rather 
than SRT in general.   
 In addition, a number of studies used a dichotomous distinction (i.e. yes versus no) to 
assess whether participants had engaged in SRT (e.g. non-condom use) at last sexual 
intercourse (i.e. Agardh et al, 2012; Turner et al 2011; Roberts et al., 2003; Murphy et al., 
2001; Marks et al, 1998). However, this type of question neglects occasions when 
participants may have engaged in unsafe sexual practices prior to the last occurrence of sex 
(which may be within close temporal proximity to the last occurrence of sex). A number of 
studies addressed this issue by asking the frequency of SRT (i.e. Camacho et al 1996; 
Bancroft et al., 2003; 2004; 2005), however conceptual disparities across studies mean that 
variation of study outcomes were likely. 
 Across the studies an issue of concern is the temporal incongruence between the SRT 
measure and the measurement of anxiety and depression symptoms (Crepaz & Marks, 
2001).  For example, participants may be asked about their SRT behaviour over the last 6-
months, but are only asked to report depressive and anxiety symptoms in the last 7-days. 
Three of the studies included in the review used incongruent measures of both anxiety and 
depression which did not map onto the timeframe assessing SRT (i.e. Agardh et al, 2012; 
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Turner et al 2011; Marks et al, 1998). Moreover, one study had an incongruent measure of 
depression in relation to SRT, but did not report temporal overlap for anxiety (i.e. Murphy 
et al., 2001), and two studies did not report the temporality of their measures for both 
anxiety and depression (i.e. Camacho et al., 1996; Roberts et al., 2011). Given that one of 
the recommendations of Crepaz and Marks (2001) following their meta-analysis was to 
address this issue of temporal incongruence, only three of the six studies published after 
this date reported having addressed the issue by adequately measuring the time of SRT in 
line with the self-report of anxiety and depression (i.e. Bancroft et al., 2003, 2004, 2005).  
 
Measurement of Anxiety and Depression 
The way in which anxiety and depression were measured also displayed considerable 
variation and have consequences for measurement incongruence identified by Crepaz and 
Marks (2001). State and trait measures of anxiety and depression assess symptoms over 
different time periods: state measures assess for transient and shorter-term feelings and so 
tend to ask participants to consider shorter periods of time when responding, whereas trait 
measures capturing broader, longer-term, and enduring characteristics of affect ask 
participants how they feel more ‘generally’. There are few standardised measures of trait 
anxiety and depression, and only three studies in the review used state measures (STAI and 
ZDPR; Bancroft et al., 2003, 2004, 2005).   
 There is also the issue of matching measures, in terms of the psychometric properties 
for specific population samples. A number of studies selected state measures of anxiety 
and depression because they had been validated for use within a specific population sample 
(i.e. adolescents, Murphy et al., 2001; drug-users, Camacho et al., 1996, and Roberts et al., 
2011; ethno-culturally specific sample, Agardh et al., 2012) and with reliability for both 
community (e.g. Murphy et al., 2001) and clinical samples (e.g. Agardh, et al., 2012). 
There is, therefore, need to identify valid and reliable trait measures of anxiety and 
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depression to overcome issues of temporal incongruence when exploring the association 
that SRT has with anxiety and depression.  
 A further issue raised by Crepaz and Marks (2001) concerns the suitability of statistical 
models used to determine the presence of a significant association in datasets. They 
suggested that those with moderate depression may be more likely to engage in SRT (as 
there is a psychological need for, and physical capacity to engage in sexual activity) than 
those with low (no psychological need to engage in sexual activity) or high (incapacitated 
by symptoms to engage in sexual activity) levels of anxiety and/or depression.  They point 
out that curvilinear analysis is more appropriate to detect such an ‘inverted U-shape’ 
relationship between anxiety and depression, and SRT. This has further implications for 
the way in which anxiety and depression are reported. Most studies tended to use a 
dichotomous distinction of anxious/depressed and not anxious/depressed, or high 
anxious/depressive scores versus low anxious/depressive scores. A richer analysis of the 
data than can be achieved by assessing differences by utilising clinical cut-off scores in 
standardised measures to differentiate low, moderate, and high level scores for anxiety 
and/or depression severity (i.e. HADS).  
 
Future Research Considerations 
Future research should involve further cross-sectional, questionnaire-based research, which 
should attempt to address the issues related to temporal incongruence between measures 
including the use, where possible, of different state and trait measures to explore 
implications for the nature of the association, and the assessment of non-linear trends in the 
data. However, in order to move the field forward, particularly in terms of understanding 
the causal nature of the association, it will be important to move beyond the current 
reliance within the field on cross-sectional designs, to the design and implementation of 
prospective longitudinal studies that follow individuals over time.  
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 Further work is also required in exploring the influences of individually occurring 
personality factors, mood, sexual desire and arousal, particularly in female populations, 
which are lacking within the extant literature. There have been developments in the form 
of a Dual Control model of sexual response, which posits that the interactive processes of 
inhibition and excitation may best explain findings observed within the literature (Janssen 
& Bancroft, 2006). Thus, future research could explore mood-related sexual desire, and 
propensity to reach orgasm as a factor influencing SRT, which may shed light upon the 
proposed inhibitory and excitation mechanisms outlined in the Dual Control model.  
 
Limitations  
To the author’s knowledge this is the first systematic review offering a narrative synthesis 
of studies evaluating association between both anxiety and depression, and SRT. In 
addition to the biases and limitations considered in the synthesis of the individual research 
studies, the systematic review process itself is not immune from such considerations.  
 Systematic reviews are employed because they can reduce the risk of bias associated 
reliance on the outcome of single studies (Gard, Hackman & Tonelli, 2008). However, the 
nature of the review process is itself open bias. For example, while the current review 
searched more databases than did an existing meta-analysis in the field (e.g. Crepaz & 
Marks, 2001) and covered a broad array of relevant disciplines, there is still the potential 
for relevant literature to have been overlooked in the synthesis. The current review 
attempted to minimise this bias by searching the reference lists of the final full papers, 
which resulted in 46 additional papers that yielded one additional study in the synthesis. 
Future reviews may benefit from conducting a search of the grey literature to minimise the 
risk of publication bias whereby positive and "interesting" results are more likely to be 
published in academic journals (Gard et al, 2008). Limitations in time and resource 
availability precluded the ability to assess the grey literature in this review. 
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In addition, the decision to include both anxiety and depression in the search, rather than 
studies that focus solely on anxiety or depression, may have restricted the conclusions that 
can be drawn in the current review. Future reviews should seek to broaden the inclusion 
criteria to address this issue.    
 
Conclusion 
The findings in this review point to a positive association between anxiety and SRT, and 
depression and SRT such that experiences of anxiety and depressive symptoms are linked 
to increased self-report of a variety of SRT behaviours. However, the nature of the 
association differs somewhat according to the study sample, and the method of measuring 
SRT, anxiety, and depression, and the interaction between these features. Indeed, the range 
of methodological and conceptual issues outlined in this review with respect to the 
individual studies and the review process itself highlight the need to interpret these 
findings with a degree of caution. The relationships between SRT and anxiety and 
depression are likely to be complex and the possibility remains that these relationships are 
moderated and mediated by the influence of a range of contextual factors.  Efforts to 
understand these relationships more fully will require further delineation and refinement of 
both conceptual definitions and methodological considerations. 
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Lay Summary 
Sexual risk-taking (SRT) behaviour such as non-condom use and having multiple sexual 
partners, poses a significant risk to health through its association with acquiring sexually 
transmitted infections, including HIV.  Conditions such as anxiety and depression have 
traditionally been associated with reduced sexual libido; however, there is now evidence 
showing that for some individuals, these conditions may actually lead to increased sexual 
libido and, engagement in SRT behaviours as a means to alleviate negative mood states. In 
addition to anxiety and depression, mood-related sexual desire (MRSD) and impulsivity 
traits may play a role in influencing SRT behaviour. This study explores the relationship 
between SRT, and anxiety and depression, along with the consideration of MRSD and 
impulsivity in an inner-city sexual and reproductive health clinic. One-hundred-and-twenty 
adult participants attending the clinic completed an anonymous survey on their 
engagement in SRT behaviour, depression and anxiety, MRSD and impulsivity. There was 
some evidence indicating that higher levels of anxiety, depression, MRSD, and impulsivity 
were associated with higher levels of various SRT behaviours. However the exact nature of 
the relationship is complex, requiring further study. This information may be important for 
identifying individuals with an increased risk of engaging in SRT that can negatively 
impact on their physical and mental health. Findings from this study may contribute 
towards the development of appropriate support to prevent engagement in risky sexual 
practices, and promote improvement in sexual health and wellbeing. 
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Abstract 
Background: Sexual risk-taking (SRT) is a primary contributor to the transmission of 
sexually transmitted infection, including HIV, and therefore poses a significant public 
health concern. Evidence suggests that the propensity to engage in SRT may be influenced 
by negative affective states (i.e. anxiety and depression symptoms), and individually 
varying characteristics (i.e. mood-related sexual desire (MRSD), and impulsivity). 
Aims: The aim of this study was to explore the association between negative affect and 
five SRT behaviours. In addition it sought to explore the association between SRT and two 
key individual characteristics, MRSD and impulsivity. 
Methods: A cross-sectional survey was completed by a convenience sample of 120 
participants (median age 25.5; 78 female) recruited from an inner-city sexual and 
reproductive health clinic.  The survey comprised 5 questionnaires relating to each of the 
key variables being explored. 
Results: Non-parametric analysis provided evidence of the existence of an association 
between various forms of SRT and negative affect; however, the nature of the association 
differed according to the type of SRT. In addition, MRSD and impulsivity demonstrated 
mainly positive associations with SRT. 
Conclusion: The findings support emerging evidence of increased engagement in certain 
forms of SRT when experiencing anxiety and depression symptoms. Moreover, the 
association with MRSD and impulsivity suggest these factors need further exploration in 
explaining the link between SRT and negative affect. This has implications for the 
development and implementation of prevention and intervention practices relating to SRT 
and mental health. 
 
Keywords: anxiety, depression, sexual risk-taking, sexual desire, impulsivity 
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Introduction 
The sexual health of Scottish citizens is poor (Scottish Executive, 2005). This is evidenced 
by a year-on-year increase in rates of sexually transmitted infections (STIs) (see: ISD 
Scotland, 2008 for most recent data). Individuals of varying sexual orientation, age, gender 
and ethnicity can be affected by STIs, including HIV transmission (WH0, 2015). The 
consequences of STIs can be significant with short- and long-term negative health 
outcomes for both men and women (Macdowell, 2002). These include (in)fertility issues, 
certain types of cancer, and in some instances premature mortality (Scottish Executive, 
2005). Sexual risk-taking (SRT) behaviour plays a significant primary role in the 
contraction and transmission of STIs (WHO, 2015). Thus, identifying and understanding 
the factors that may lead individuals to engage in SRT has important implications for the 
prevention of STIs and promotion of sexual health. 
 
Sexual Risk-Taking Behaviour 
Sexual risk-taking encompasses a broad range of behaviours, however there are a core 
element of behavioural measures that are generally accepted (e.g. Slaymaker, 2004), 
including: unprotected sex, sexual debut, number of sexual partners, involvement in sex 
trading (i.e. prostitution), and type of sexual partner (i.e. long-term versus casual). 
Engagement in sexual activity, including SRT, can be used to regulate and improve 
anxious and depressive mood states (Lykins, Janssen & Graham, 2006); however, this is a 
relatively recent assertion, as previously it was commonly assumed that reduced sexual 
libido (i.e. sexual desire and arousal) was a secondary symptom of those experiencing 
anxiety and depression (e.g. Figueira, et al., 2001; Beck, 1967). Indeed, for a significant 
proportion of individuals with anxiety
 
(e.g. Ware et al., 1996) and/or depression (e.g., 
Bancroft et al, 2004) sexual libido is unchanged or can be increased. Moreover, both of 
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these common mental health disorders have been linked to increases in SRT (see Bancroft 
et al., 2005). 
 
Common Mental Health Disorders 
The term “common mental health disorders” refers to a set of commonly occurring mental 
health conditions within the general population such as generalised anxiety disorder, social 
anxiety, and depression (NICE, 2011). A profile of mixed anxiety and depression is the 
most frequently occurring co-morbidity, with relatively few people receiving a depression 
or anxiety diagnosis in isolation (Singleton et al., 2001). Indeed, evidence suggests that 
individuals with comorbid disorders (e.g. anxiety and depression) are more likely to 
engage in SRT than those with no mental health disorder (Ramrakha et al., 2000). It would 
therefore be informative for any study interested in exploring the relationship between 
SRT and anxiety and depression, to evaluate both of these forms of common mental 
disorders together. 
 
Sexual Risk-Taking in the Context of Negative Affect 
The relationship between SRT and negative affect is complex, with contradictory evidence 
about the nature of these relationships (Janssen et al., 2013).  Emerging evidence indicates 
that individuals experiencing anxiety and/or depression may be more likely to engage in 
SRT (e.g. Mazzaferro et al., 2006; Rubin et al., 2009). This may in part be linked to a 
behavioural strategy that serves to reduce tension, and cope with stress (Folkman et al., 
1992). Indeed, such negative affective states can significantly impede cognitive 
performance resulting in risk appraisal and problem solving deficits, and impairment in 
self-directed positive and protective behaviour (Canin et al. 1999). The only meta-analysis 
in the field found insufficient evidence to support the hypothesis that anxiety and/or 
depression is associated in any way with SRT behaviour (Crepaz & Marks, 2001). 
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However, Bancroft et al., (2003) assert that the tendency for negative affect to increase 
SRT in some individuals and reduce it in others would account for the “nil effect” found in 
the meta-analysis. This highlights the potential role of individual differences in moderating 
the relationship between anxiety and/or depression and SRT.  
 
Moderating Factors in the Relationship Between Negative Affect and Sexual Risk-
Taking 
The relevance of personality and other individually orientated variables has been explored 
within the context of the relationship between negative affect and SRT. In a series of cross-
sectional studies, Bancroft and colleagues investigated the relevance of sexual arousability 
and sensation-seeking and found that in heterosexual males they accounted for 19% of the 
variance in their Mood Sexuality Questionnaire (Bancroft et al., 2003) whereas in 
homosexual males they found a more complicated relationship whereby only 4% of the 
variance in mood-sexuality was accounted for (Bancroft et al., 2003). Janssen and Bancroft 
note that a number of moderating variables can help explain the paradoxical relationship 
between negative mood and SRT. In addition to severity of anxious and depressive 
symptoms, additional key personality-related moderating variables include mood-related 
sexual desire (MRSD) and impulsivity (Bancroft et al., 2004). 
  
Sexual Risk-Taking in the Context of Mood-Related Sexual Desire 
Individual differences arising from the unique personal experience of anxiety and 
depression are relevant when considering the effect of MRSD on SRT. Since the late 1960s 
it has been reported that anxiety (e.g. Kaplan, 1988) and depression symptoms (e.g. Beck, 
1967) reduce sexual libido. However, a body of evidence has emerged highlighting that 
this may not be the case for a significant proportion of individuals experiencing anxiety 
and depression symptoms (Bancroft et al., 2003). For some, sexual desire may actually 
  50 
increase when anxious (e.g. Ware et al., 1996) and depressed (e.g. Bancroft et al, 2004) 
and thus moderate SRT. This may reflect a need to seek sexual contact for the purpose of 
mood regulation, sexual pleasure, need for intimacy and self-validation, or to simply feel 
calmer following orgasm (Bancroft et al., 2003). Moreover, there is evidence to suggest 
that the tendency to experience increased sexual desire when anxious and depressed may 
be associated with a stronger tendency to engage in regrettable sexual behaviours (Janssen, 
Macapagal, & Mustanski, 2013). 
 In a comprehensive attempt to quantify the effects of negative affective states on 
sexuality, Bancroft et al. (2003), designed the Mood Sexuality Questionnaire (MSQ), 
which was superseded by the MSQ-Revised (Janssen et al., 2013). These are the first 
scales to ask individuals to self-report personal, real-life experiences on the general effects 
of anxiety and depression on their sexual desire and response. Prior to the development of 
these measures research investigating association between mood states and sexuality were, 
for the most part, inferred by calculating correlations between, for example, anxiety and 
depression measures and sexual physiological response, and through experimentation 
using mood induction methods (see Janssen et al., 2013). While the MSQ seeks to capture 
participant responses on the effects of negative affect on their sexual desire and anticipated 
behavioural response, the MSQ-R goes further in its ability to measure some of the 
intricate and complex dimensions in the relationship among mood states (see MSQ-R in 
method). 
 The considerable variability in how negative affect influences MRSD, and the effect 
upon sexual behaviour has been reported in a mixed population sample (Janssen et al., 
2013). It was found that heterosexual women were less likely than heterosexual and 
homosexual men to experience increased MRSD when anxious, and homosexual men and 
heterosexual women were less likely to experience increased MRSD when depressed 
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(Janssen et al., 2013).
 
This highlights the importance of individual differences in the way 
MRSD influences regrettable sexual behaviour.  
 
Sexual Risk-Taking in the Context of Impulsivity 
Impulsivity has been a popular area of interest for investigators seeking to understand the 
relationship between personality constructs and risky, externalising behaviours, including 
substance misuse (e.g. Boschlooa, 2013), physical violence (e.g. Krueger, 2007) and SRT 
(e.g. Deckman & DeWall, 2011). More specifically, it has been found that individuals 
identified as anxious and depressed had higher impulsivity scores than individuals who are 
not anxious (e.g. Del Carol et al., 2012) or depressed (i.e. Corruble et al., 2003) supporting 
a potential moderating role of impulsivity in the association between SRT and negative 
affect (Dudley et al., 2004). 
 
 Impulsivity has been conceptualised and measured in a variety of different ways 
(Cyders et al., 2014). The development of the UPPS model of impulsivity (see Whiteside 
& Lynam, 2001) highlighted the multi-dimensional nature of impulsivity, originally 
proposing four dimensions which were expanded to five following further research, 
(Cyders & Smith, 2008):  
 
 Positive Urgency: propensity for rash action when in positive mood states 
 Negative Urgency: propensity for rash action when in negative mood states 
 Premeditation (lack of): propensity not to consider consequences of one’s actions 
 Perseverance (lack of): propensity to experience difficulty remaining focused on 
challenging and boring tasks 
 Sensation seeking: tendency to favour stimulating or exciting activities 
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 Despite this, the majority of studies examining the effect of impulsivity on SRT focus 
on one of five factors – most commonly sensation-seeking (e.g. Bancroft 2003, 2004, 
2005). This is likely due to the substantial body of evidence supporting the association 
between sensation-seeking and SRT (Hoyle et al., 2000). However, Birthrong and Latzman 
(2014) found that sensation-seeking and (lack of) perseveration were not significantly 
associated with SRT, and asserted that an examination of sensation-seeking alone is 
insufficient when evaluating the influence of impulsivity on SRT. It is therefore important 
any study of impulsivity uses a measure that accounts for the complexity of the construct. 
 
The Current Study 
Given the broad public health implications of STIs, it is essential to elucidate risk factors 
associated with SRT. The majority of studies seeking to ascertain the effects of negative 
affective states on SRT have returned inconsistent and complex findings. The considerable 
heterogeneity in outcomes and limited exploration of individual differences places 
limitations upon informing clinical practice and public health policy. This exploratory 
study considers some of the apparent limitations identified relating to the association 
between anxiety and depression with SRT, and the role of individual differences (i.e. 
MRSD and impulsivity) in a clinical sample.  
 
Hypotheses 
The following hypotheses will be tested: 
 
Hypothesis 1a: Individuals with anxiety symptoms will exhibit increased levels of SRT 
compared to non-anxious individuals. 
Hypothesis 1b: Individuals with anxiety symptoms will exhibit increased propensity for 
impulsivity, compared to non-anxious individuals. 
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Hypothesis 1c: Individuals who rate highly on MRSD when anxious will exhibit higher 
levels of SRT than individuals who rate low. 
Hypothesis 1d: Individuals who rate highly on MRSD when anxious will exhibit higher 
levels of impulsivity than individuals who rate low. 
Hypothesis 2a: Individuals with depression symptoms will exhibit increased levels of SRT 
compared to non-depressed individuals. 
Hypothesis 2b: Individuals with depression symptoms will exhibit increased propensity 
for impulsivity compared to non-depressed individuals. 
Hypothesis 2c: Individuals with who rate highly on MRSD when depressed will exhibit 
higher levels of SRT than individuals who rate low. 
Hypothesis 2d: Individuals who rate highly on MRSD when depressed will exhibit higher 
levels of impulsivity than individuals who rate low. 
 
Method 
Ethical approval for the study was granted by the National Research Ethics Service prior to 
recruitment (15/WS/0023; see Appendix III). 
 
Participants  
A convenience sample of 120 adults (median age 25.5, IQR 21-33) attending an inner-city 
sexual and reproductive health clinic, situated within NHS Greater Glasgow and Clyde 
(NHSGGC) in Glasgow between March and May 2015 were recruited (see Table 5 for 
participant demographics).  
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Table 5 
Participant characteristics 
  Median Range Inter-quartile range 
Age 25.5 17-68 21-33 
        
Education status       
Number of years 14 2-22 12-17 
  
 
    n  (%)     
Level of education (missing n=2)        
    Up to secondary (complete) 13 (10.8)     
    Up to college (complete) 20 (16.7)     
    Up to University (complete) 44 (36.7)     
    Attending college or university    41 (34.2)     
        
Gender (missing n=1)       
Male 41 (34.2)     
Female 78 (65.0)     
        
Employment (missing n=1)       
Full-time 49 (40.8)     
Part-time 21 (17.5)     
Unemployed 18 (15.0)     
Full-time education 31 (25.8)     
 
Ethnicity       
White 111 (92.5)     
Other Asian 3 (2.5)     
Black African 1 (0.8)     
Other 5 (4.2)     
        
Income per annum (missing n=1)       
Below 10k 62 (51.7)     
11-20k 25 (20.8)     
21-30k 13 (10.8)     
31-40k 8 (6.7)     
41-50k 9 (7.5)     
51k + 2 (1.7)     
        
Sexual Orientation (missing n=2)       
Heterosexual 86 (71.7)     
Homosexual 11 (9.2)     
Bisexual 18 (15)     
Uncertain 3 (2.5)     
 
      
Current sexual partner (missing n=2)       
Yes  90 (75.0)     
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No  28 (23.3)     
        
Relationship status (missing n=1)       
Exclusive/monogamous 73 (60.8)     
Non-exclusive/non-monogamous 18 (15.0)     
No relationship 28 (23.3)     
        
Marital status (missing n=1)       
Single/never married 94 (78.3)     
Cohabiting 13 (10.8)     
Married 4 (3.3)     
Civil partnership 4 (3.3)     
Separated/divorced 4 (3.3)     
 
The clinic receives the majority of their patients via self-referral; however, many are 
referred from practitioners associated with local and regional community and acute health 
and social care settings. Services include community gynaecology, genitourinary medicine 
(e.g. STI assessment and treatment, including HIV testing), psychosexual medicine and 
counselling, termination of pregnancy, and acute sexual health emergencies. Despite being 
an inner-city clinic, the typical patient demographic varies considerably throughout the 
year, which is dependent on a number of factors such as the close proximity of temporary, 
short-stay asylum seeker housing, and educational institutions, including nearby 
Universities.  The participant sample corresponds fairly closely with that of the patient 
group attending the clinic over the study period (1
st
 March to 31
st
 May 2015) on a number 
of key demographic variables (see Table 6). Thus, the sample can be considered broadly 
representative of the patient population. 
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Table 6 
Comparison of demographic data for participant sample with population of clinic 
attending patients for the period between - 1
st
 March and 31
st
 May 2015 
  Population n (%) Sample n (%) 
Clinic attending patients  18921 120 
      
Gender (missing n=1)      
Female 13712 (72.46)  78 (65.0) 
Male 5209   (27.53) 41 (34.16)  
      
Sexual orientation 
    Heterosexual 16141 (85.87)  86 (71.66) 
Homosexual 2780 (14.69) 11 (9.16)  
 
Age     
<16 358 (1.89)  0 
16-19 2362 (12.48)  21 (17.5) 
20-29 8031 (42.44)  57 (47.5) 
30-39 4511 (23.84)  24 (20.0) 
40-49k 2514 (13.28)  12 (10.0) 
50 + 1210 (6.39)  6 (5.0) 
      
Ethnicity (not recorded n=1941)     
White 14826 (78.35)  111 (92.5) 
Other 1277 (6.74)  5 (4.16) 
Asian (South & Other) 426 (2.25)  3 (2.5) 
Black (African & Other) 318 (1.68)  1 (0.83) 
   Chinese 138 (0.72) 0 
 
Justification for sample size  
The study is an exploratory study, and to the author’s knowledge no similar study exists in 
the examination of anxiety and/or depression symptoms, MRSD, impulsivity and SRT. It 
is, therefore, not possible to draw on existing effect sizes to calculate a sample size to 
ensure this study is sufficiently powered.  The results of this study will be used to generate 
effect sizes that will facilitate sample size estimate for future research. However, Table 7 
shows the power values assuming that anxiety/depression had a correlation with SRT (r = 
0.4) and setting alpha at 0.025 (two-tailed). 
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Table 7  
Power and effect size calculation obtained using G*Power 3 (Faul et al., 2007).
 
Power 0.60 0.65 0.70 0.75 0.80 0.85 0.90 
Sample size 52 58 65 73 82 93 109 
 
 The aim was to recruit up to 109 participants within the 12-week recruitment phase 
between 9
th
 March and 31
st
 May 2015.  The sexual health clinic was visited by 11,556 
attendees during this time frame in 2013 (Sandyford, 2013) thereby it was estimated that 
less than 1.0% of possible attendees would be required to participate to achieve a sample 
size necessary to yield a moderate effect.  
 
Design  
This study employed a cross-sectional survey design to explore the association between 
symptoms of anxiety and/or depression, SRT, MRSD, and impulsivity within a sexual 
health clinic population sample. 
 
Measures  
The survey comprised five elements:   
 
Demographic and sexual information questionnaire (adapted from Socio-sexual 
Orientation Inventory [SOI], Simpson & Gangestad, 1991; SOI-revised, Seal & 
Agostinelli, 1994) 
This measure captures a range of demographic and historical data, and SRT behaviours: 
age, gender, ethnicity, education level, employment status, sexual orientation, relationship 
status, frequency of sexual activity (not necessarily intercourse) in the last week; frequency 
of sexual activity with a partner (not necessarily intercourse) in the past 12 months; 
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number of different partners with whom sexual intercourse occurred in the past 12 months; 
number of single-occasion sexual partners (i.e. one night stands) in a lifetime; and number 
of sexual partners with whom safe-sex was not practiced. Completion time is 
approximately 2-3 minutes. 
 
Hospital Anxiety and Depression Scale (HADS) (Zigmond & Snaith, 1983)  
This measure is a widely used 14-item self-administered screening tool for the 
identification of caseness for anxiety and depression in clinical and non-clinical 
populations. It was specifically designed to detect state-level anxiety, and depression and 
emotional distress in patients undergoing clinical treatment in such a way to reduce the 
confounding effect of somatic symptoms associated with physical health conditions (e.g. 
fatigue). Completion time for the 14 items (7 for the anxiety subscale; HADS-A, and 7 for 
the depression subscale; HADS-D) is approximately 2-3 minutes, which are scored 
according to four response options ranging from ‘not at all’ (0) to ‘most of the time’ (3). 
The total score is summed to give anxiety, and depression scores, and an overall emotional 
distress score. The scale has good reliability and validity, which varies from .40 to.74 (M = 
.56) and Cronbach's alpha for HADS-A varies from .68 to .93 (M = .83) and for HADS-D 
from .67 to .90 (M = .82) (Zigmond & Snaith, 1983).  
 
Short (English version of the) Urgency, Premeditation, Perseverance, Sensation-
Seeking-Positive Scale (SUPPS-P) (Cyders et al., 2014)
  
This
 
is a 20-item self-report measure that assesses five facets of impulsivity (i.e. sensation-
seeking, e.g. “I would like to fly an aeroplane”; (lack of) perseverance, e.g. “I finish what I 
start”; (lack of) premeditation, e.g. “I usually think carefully before doing anything”; 
negative urgency, e.g. “When I am upset I often act without thinking”; and positive 
urgency, e.g. “I tend to lose control when I am in a great mood”) in adults and adolescents. 
  59 
Completion time is approximately 2-3 minutes. Each factor is measured by four items, 
each of which is scored on a 4-point scale ranging from ‘strongly agree’ (1) to ‘strongly 
disagree’ (4). The points attributed to each item of a given factor can be added to form a 
total score, and an overall composite score can be calculated. Each factor subscale on the 
short version has adequate reliability, internal consistency (Cronbach alphas = 0.74-0.88 
across subscales) and inter-scale correlations that compare favourably to the original long 
version (Cyders et al., 2014). 
 
Revised Mood and Sexuality Questionnaire (MSQ-R) (Janssen, et al., 2013)  
This is a self-report trait measure that explores how mood (i.e. anxiety/stress, 
sadness/depression, and happiness/cheerfulness) influences sexual desire, arousal, 
masturbation frequency, and sexual behaviours that may be later regretted). The 
questionnaire comprises eight subscales, the internal consistency of each has been found to 
be sufficiently high. However, for the purposes of this study only two subscales were used 
in the analysis of MRSD: Anxiety-desire (AnxDes) and Depression-desire (DepDes) (e.g. 
“When I feel anxious/stressed [or] sad/depressed, I think about sex”). Higher scores 
indicate a propensity for greater desire to have sex when anxious/stressed and 
sad/depressed. Cronbach alphas for the AnxDes measure are .87 for heterosexual men, .84 
for heterosexual women, and .86 for homosexual men (Janssen et al., 2013). For the 
DepDes measure Cronbach alphas were .87 for heterosexual men, .86 for heterosexual 
women, and .87 for homosexual men (Janssen et al., 2013). Completion time 
approximately 3-5 minutes. 
 
Research Procedures 
Individuals wishing to seek the services of the sexual and reproductive health clinic 
registered their attendance with the receptionist following walk-in or scheduled 
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appointment. They were then offered a Participant Information Sheet (PIS) so as to make 
an informed decision regarding their participation. Due to the anonymous nature of the 
study participants were not required to provide personal information or a signature to offer 
consent, but rather, completion of the survey implied their consent to participate. 
Participants who had completed the survey that reported their age to be 16 and below were 
excluded. Individuals were informed they could opt-out of the study at any time without 
reason, but given the anonymous nature of the survey, their data could not be withdrawn at 
a later date. 
 Participants were offered three options to complete the survey (see Figure 2): 1. on-site 
using a paper format of the survey either prior to or following appointment which could be 
returned in deposit boxes provided; 2. off-site using a paper survey, which could be 
returned using a stamp-addressed envelope; or 3. off-site using an electronic version of the 
survey, which could be accessed via an internet web-link provided on the PIS. 
 The survey took approximately 10-15 minutes to complete. The PIS was explicit in 
stating that participation would require self-reflection on their current mental health status 
and sexual history. All participants were offered contact details of supportive organisations 
(e.g. Samaritans, SAMH etc.), NHS-24, and directions on how to obtain 1-to-1 supports 
from the Sandyford Listening Ears Counselling Service. Participants were encouraged to 
make contact with their G.P with any concerns surrounding their physical or mental health, 
which may have arisen following participation in the study. 
 The email and telephone numbers of three contact persons were provided on the PIS, 
one of which was an independent contact, and one whom was on-site at all times to answer 
questions and ensure participant comfort and safety. No clinicians took part in advertising 
or data collection processes. Participation did not affect any aspect of care or treatment. 
Participants were reminded that they should not provide any personal identifiers.  
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Data Analysis  
While data collected from Likert-type scales (that denote specific categories of response) 
are often treated as interval data (at least) and analysed using parametric tests (when 
assumptions are met), it should be treated as ordinal level data necessitating non-
parametric analysis (Field, 2009). The HADS, SUPPS-P, and MRSD subscales of the 
MSQ-R require participants to self-report on Likert-scales, and as such were treated as 
ordinal in the analysis. As ordinal level data violates a core assumption for the use of 
parametric tests the appropriate non-parametric equivalents were used.  
 Analysis involved data on each of the measures in its raw form and transformed into 
categories. Raw data for HADS-A and HADS-D were transformed into three categorical 
values according to the recommended clinical cut-offs for optimal identification of 
asymptomatic (score 0-7), borderline symptomatic (score 8-10), and symptomatic (score 
11-21) groups (Zigmond & Snaith, 1983; Bjelland et al., 2002). However, there was an 
imbalance in the number of participants across the categories on HADS-D: asymptomatic 
group n=89, borderline n=13, and symptomatic n=18. Thus, to improve the power of the 
analysis an alternative cut-off, recommended for use in primary care (e.g. Wilkinson & 
Barczak, 1988) and out-patient samples (e.g. Olsson, Mykletun, & Dahl, 2005), was 
employed whereby a score of 0-7 is used to denote asymptomatic and a score of  ≥8 to 
denote symptomatic. 
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                     Figure 2. Flow chart illustrating participant recruitment process 
  
 The raw data for SUPPS-S and each of its five subscales were transformed into 
categorical values as proposed by Cyders et al., (2014) creating four groups (1= no 
endorsement of impulsivity, 2= low, 3= moderate, and 4= high levels of self-report 
impulsivity). Following exploration of each category size there was an imbalance in the 
number of participants across each of these groups on perseveration (high score n=3) and 
premeditation (high score n=4). Thus, at the expense of losing variation, the high and 
moderate categories were combined for these scales only to create a moderate/high 
category (perseveration n=22, and premeditation n=32) to improve the power of the 
analysis. It is worth noting that Cyders et al., (2014) proposed using the mean of the items 
y 
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to identify the category into which an individual falls. However, as the data is ordinal, it is 
more appropriate to take the median of the scores in order to categorise the data.  
Finally, raw data for the AnxDes and DepDes subscales of the MSQ-R were categorised 
into high and low groups using a median split.  
 Statistical analysis was undertaken using IBM Statistical Package for the Social 
Sciences (SPSS) version 22. Bivariate correlational analysis using Spearman’s Rho was 
conducted on the raw data to determine the associations between the variables and each of 
the five SRT factors and six scores derived from SUPPS-P (as appropriate). To minimise 
the risk of Type I error resulting from undertaking multiple correlations Bonferroni 
adjustments were calculated. For correlations involving the five factors of SRT the 
adjusted alpha value was .01; whereas for correlations involving the six scores derived 
from SUPPS-P the adjusted alpha value was .008. 
 To explore differences between the categories on the various scales and subscales for 
each of the five SRT factors and six scores derived from SUPPS-P (as appropriate), 
independent between groups comparisons were undertaken. For comparisons between 
multiple groups (i.e. HADS-A and SUPPS-P scores) Kruskal-Wallis tests were used, and 
post-hoc comparisons were made by SPSS with an automatic adjustment to correct the p-
value. For comparisons between two groups (i.e. HADS-D and the two MRSD subscales) 
Mann-Whitney U tests were used. 
 As the study is exploratory in nature, both adjusted and unadjusted alpha values will be 
presented as well as findings approaching significance (p<.10). This is typical in 
exploratory research because methods of adjusting alpha to account for multiple 
comparisons can be conservative, particularly the Bonferroni correction, thereby increasing 
the risk of Type II error (Field, 2009).  
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Results 
To begin, details of the participants are provided, which is followed by the presentation of 
the results of the inferential statistics according to the study hypotheses. 
 
Participant Characteristics 
One hundred and twenty six participants completed the survey. Table 5 provides 
descriptive data relating to the participants. Six participants were excluded due to 
missing/incomplete data. There was a greater proportion of female (65%) than male 
participants, and predominantly of white ethnicity (92.5%). The majority were in full- or 
part-time employment (70%), however over 50% of these participants earned below 
national average wages of £10k per annum. Most of the participants were in 
exclusive/monogamous relationships (60.8%), were heterosexual (86%), and had never 
been married (94%). Over 80% of the participants had previously had an STI test, of these 
33% had a positive result.  
To evaluate the effect of key demographic variables such as age, gender, educational 
level etc. sub-group analyses was considered. However, due to the small numbers in some 
of the demographic categories, such analyses would have been underpowered and so it was 
not meaningful to undertake sub-group analysis (see Appendix IV for demographic 
category frequencies). 
 
Sexual Risk-Taking, Anxiety and Depression (Hypotheses 1a and 2a) 
Spearman’s Correlation Coefficients were conducted to explore the association between 
HADS-A, and HADS-D scores with each of the five SRT factors (see Table 8). Significant 
negative correlations were found for both HADS-A and HADS-D with number of times a 
person had sex within the last week (-.188, p=.020 and -.215, p=.009 respectively), and 
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positive correlations with the number of one night stands in a lifetime (.163, p=.038 and 
.338, p<.001, respectively). All other correlations were non-significant. 
 To explore the differences between the three groups on HADS-A and the two groups on 
HADS-D for each of the five SRT measures non-parametric omnibus tests were first 
conducted.  
 An independent samples Kruskal-Wallis test indicated that there was a significant 
difference in the number of one-night stands for HADS-A (H(2) = 9.49, p < .01). All other 
tests were non-significant (p > .05). Multiple pairwise comparisons, with an adjustment of 
the alpha level were performed across the three categories of HADS-A and found a 
statistically significant difference in the number of one-night stands in a lifetime between 
those categorised as asymptomatic on the HADS-A scale and those categorised as 
borderline (p<.01), with the difference between those categorised as asymptomatic and 
symptomatic just failing to reach significance (p=.054). 
 Independent samples Mann-Whitney U test indicated that those categorised as 
depressed on the HADS-D scale reported significantly more one night stands in a lifetime 
than those categorised as asymptomatic  (U=3.00, p<.01). All other tests were non-
significant (p > .05). 
 
Anxiety, Depression, and Impulsivity (Hypotheses 1b and 2b) 
Spearman’s correlation coefficients were calculated for HADS-A and HADS-D with the 
six SUPPS-P factors (see Table 8). Significant positive correlations were found between 
HADS-A scores and the composite impulsivity score, and three of the subscales. Similarly, 
positive correlations were found between HADS-D scores and the composite impulsivity 
score, and two of the subscales, with one subscale approaching significance. To explore 
the differences between the three groups on HADS-A and the two groups on HADS-D for 
each of the six SUPPS-P factors non-parametric omnibus tests were conducted. 
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Table 8 
Spearman’s rho correlations for all variables explored 
 
 
 
 
 
 
 
 
 
Note: 
*denotes significance with adjusted p-value for SRT # denotes significance with adjusted p-value for SUPPS-P 
 SRT 1: frequency of sexual activity (not necessarily intercourse) in the last week; SRT 2: Frequency of sexual activity with a partner (not 
necessarily intercourse) in the past 12 months; SRT 3: Number of different partners with who sexual intercourse occurred in the past 12 months; 
SRT 4: Number of one-night-stands with different partners in the lifetime; SRT 5: Number of different partners with who unprotected sex was had 
in past 12 months 
 
SRT  SUPPS-P 
SRT 1 SRT 2 SRT 3 SRT 4 SRT 5 Comp NegUrg PosUrg Premed Persev S-S 
HADS-A 
rs=-.188, 
p=.020 
rs=-.11, 
p=.127 
rs=-.026 
p=.390 
rs=.163, 
p=.038 
rs=.077 
p=.202 
rs=.453 
p=.000# 
rs=.629 
p=.000# 
rs=.436 
p=.000# 
rs=.269 
p=.001# 
rs=-.017 
p=.428 
rs=-.009 
p=.461 
            
HADS-D 
rs=-.215, 
p=.009* 
rs=-.149 
p=.053 
rs=.053 
p=.281 
rs=.338, 
p=.000* 
rs=.123 
p=.090 
rs=.299 
p=.000# 
rs=.416 
p=.000# 
rs=.281 
p=.001# 
rs=.141 
p=.063 
rs=.030 
p=.374 
rs=.022 
p=.405 
            
AnxDes 
rs=.117 
p=.103 
rs=.104 
p=.129 
rs=.283, 
p=.001* 
rs=.232, 
p=.006* 
rs=.283, 
p=.001* 
rs=.262 
p=.002# 
rs=.118 
p=.101 
rs=.259 
p=.002# 
rs=.201 
p=.014# 
rs=.142 
p=.062 
rs=.145 
p=.057 
            
DepDes 
rs=-.005 
p=.477 
rs=.067 
p=.234 
rs=.064 
p=.245 
rs=.109 
p=.119 
rs=.054 
p=.279 
rs=.345 
p=.000# 
rs=.344 
p=.000# 
rs=.290 
p=.002# 
rs=.157 
p=.044# 
rs=.067 
p=.268 
rs=.173 
p=.030 
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Independent samples Kruskal-Wallis tests indicated that there were significant differences 
for HADS-A groups in terms of SUPPS-P composite score, and the negative urgency, 
positive urgency, and premeditation subscales (see Table 9). All other tests were non-
significant (p>.05). Multiple pairwise comparisons with an adjustment of the alpha  
 level were performed across the three categories of HADS-A for each significant outcome 
(see Table 9). 
 
Table 9 
Significant outcomes for analysis of HADS-A groups on scores derived from SUPPS-P 
Impulsivity measure Kruskal-Wallis test Post-hoc comparisons 
SUPPS-P total score H(2)=20.748 
p<.001 
Asymptomatic v. Symptomatic, p<.001 
Borderline v. Asymptomatic, p=.054 
Negative Urgency H(2)=38.996 
p<.001 
Asymptomatic v. Symptomatic, p<.001 
Borderline v. Asymptomatic, p=.001 
Premeditation H(2)=6.378 
 p=.041 
Asymptomatic v. Symptomatic, p=.035 
Positive Urgency H(2)=21.357 
p<.001 
Asymptomatic v. Symptomatic, p<.001 
Borderline v. Asymptomatic, p=.026 
 
 Independent samples Mann-Whitney U tests indicated that those categorised as 
symptomatic on HADS-D had a significantly higher SUPPS-P composite score (U=2.236, 
p=.025) and negative urgency subscale score (U=2.771, p=.006),  than those categorised as 
asymptomatic. All other tests were non-significant (p > .05). 
 
Mood-Related Sexual Desire, and Anxiety and Depression (Hypotheses 1c and 2c) 
Spearman’s correlation coefficients were calculated for AnxDes and DepDes scales with 
the five SRT measures (see Table 8). Significant positive correlations were found between 
AnxDes and the number of different partners in the past 12-months (rs=.283, p=.001) the 
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number of one night stands in a lifetime (rs=.232, p=.006), and the number of times having 
had unprotected sex in past 12-months (rs=.283, p=.001). All other correlations were non-
significant. There were, however, no significant correlations between DepDes and any of 
the SRT measures (p>.05). 
 Independent samples Mann-Whitney U tests indicated that those categorised as high on 
AnxDes reported significantly higher numbers of sexual partners in the last week 
(U=2.045, p=.041), the number of different sexual partners in the past 12-months score 
(U=2.656, p=.008), and number of occasions of unprotected sex in the past 12-months 
(U=2.838, p=.005) than those categorised as low.  All other tests were non-significant 
(p>.05).  
Independent samples Mann-Whitney U tests indicated that those categorised as high on 
DepDes reported significantly higher numbers of different sexual partners in the past 12-
months (U=2.041, p=.041) than those categorised as low.  All other tests were non-
significant (p>.05). 
 
Mood-Related Sexual Desire and Impulsivity (Hypotheses 1d and 2d) 
Spearman’s correlation coefficients were calculated for AnxDes and DepDes scales with 
the six SUPPS-P factors, identifying a number of significant positive correlations (see 
Table 8) 
 Independent samples Mann-Whitney U tests indicated that those categorised as high on 
AnxDes reported significantly higher SUPPS-P composite scores (U=2.654, p=.008), and 
premeditation (U=2.057, p=.040) and positive urgency subscale scores (U=2.840, p=.005) 
than those categorised as low.  All other tests were non-significant (p>.05). 
 Independent samples Mann-Whitney U tests indicated that those categorised as high on 
DepDes reported significantly higher SUPPS-P composite scores (U=2.458, p=.014), 
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negative urgency (U=2.876, p=.004) and positive urgency subscale scores (U=2.155, 
p=.031) than those categorised as low.  All other tests were non-significant (p>.05). 
 
Discussion 
This study aimed to explore the relationship between negative affect (anxiety, and 
depression symptoms) and sexual risk-taking (SRT), along with two key variables mood-
related sexual desire (MRSD) and impulsivity. The determination of conditions under 
which negative affect and personality factors are associated with SRT is crucial in 
supporting further conceptual and theoretical development, but also in clinical application 
leading to the creation of interventions for individuals at greatest risk of contracting STIs.  
The findings presented in this exploratory study align with the wider literature in many 
respects, demonstrating the complex nature of the association between SRT and negative 
affect (anxiety and/or depression). First, the presence of at least one significant correlation 
or group difference between the various measures of SRT and negative affect offers further 
evidence suggestive of a paradoxical relationship between anxiety and depression and 
SRT, such that it may demonstrate a negative association under some circumstances, and a 
positive association under others (e.g. Bancroft et al., 2004). Secondly, given the higher 
MRSD in those experiencing negative affective states suggests an increased desire for sex 
during negative affective states. Thirdly, the greater levels of reported impulsivity were 
associated with greater levels of SRT. In particular, the findings from the subscales 
demonstrated the need to treat impulsivity as a multi-dimensional construct. Finally, higher 
levels of reported desire for sex during anxious and depressive states were associated with 
greater levels of impulsivity, which raises important questions for the influence of these 
variables on SRT as potential moderators. Each of the hypotheses is addressed in relation 
to the findings. 
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Relationship Between Sexual Risk-Taking and Negative Affect 
Two of the five measures of SRT were found to have an association with both anxiety and 
depression: frequency of sexual activity in the last week demonstrated negative 
associations, and number of one night stands with different partners in a lifetime 
demonstrated positive associations. These findings appear to highlight temporal specificity 
for two SRT behaviours, and no associations for the other three, which reflects the 
contradictory evidence in the literature (see Crepaz & Marks, 2001). However, careful 
reflection is warranted when interpreting these findings. Most notably, the strength of 
interpretation is limited beyond the two-week time frame in which negative affect was 
measured against SRT behaviours spanning over 12-months and a lifetime. However, this 
paradoxical pattern of associations highlights the multifaceted nature of SRT (see 
Slaymaker, 2004). Indeed, the null or significant associations found in previous studies 
could be attributed to the use of different measures of SRT, within different population 
samples, and with varied temporal measurements of negative affect. Moreover, a potential 
explanation for the negative association found, may be because a proportion of the 
participants in this study may have been attending a return or follow up appointment for 
STI medical treatments (e.g. anti-biotics). The efficacy of a STI treatment is dependent 
upon abstinence from sexual contact with a partner, of which patients are routinely advised 
upon commencement of treatment.  
 The between groups comparison shed further light on the nature of the relationships, but 
in both cases the only significant difference was for number of one night stands with 
different partners in the lifetime. For this difference was between the asymptomatic and 
borderline levels of anxiety and between the asymptomatic and symptomatic levels of 
depression. However, given the small numbers in the depressed symptomatic group (n=3) 
which resulted in utilising the alternative cut-off to create two groups, the majority of 
participants in the new depressed symptomatic group would have previously been 
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categorised as borderline. Thus there is a degree of congruence between the finding for 
levels of anxiety and depression, which is reported in the wider literature (e.g. Turner et 
al., 2011; Roberts et al., 2003). This may reflect high rates of co-morbidity among anxiety 
and depressive disorders, with relatively few people receiving a single diagnosis in 
isolation (Singleton et al., 2001). 
 Moreover, in their meta-analysis Crepaz and Marks (2001) concluded that there was no 
evidence of any link between SRT and negative affect. They did, however, note that the 
reviewed studies may have adopted statistical models that failed to account for the 
possibility that individuals experiencing moderate anxious/depressive symptoms may be 
more likely to engage in SRT behaviour than those experiencing low or high levels of 
anxiety or depression. The proposed explanation was that those with more severe 
symptoms may experience lower levels of sexual libido (e.g. MRSD), such that it may 
preclude engagement in sexual activity (e.g. Bancroft et al., 2005).  Using the clinically-
relevant three group categorisation method for anxiety scores as proposed by the HADS 
(Zigmond & Snaith, 1983) the findings of this study fit with the proposal that those with 
moderate levels of anxiety and depression are more likely to engage in SRT. Despite the 
fact that the depression scores were categorised into two groups, one could argue that the 
symptomatic category in the present study captures mostly individuals with low-moderate 
levels of depression. Thus, it could be argued that for both moderate levels of anxiety and 
depression the relationship with the number of one night stands in a lifetime may be 
explained by the self-medicating hypothesis linking the calming effects of orgasm for 
anxiety and self-validation, need for intimacy, and mood regulation for depression 
(Bancroft et al., 2003). Consequently, it may be that individuals with low-moderate 
symptoms may be less affected by the inhibitory effects associated with elevated levels of 
anxiety and depression, which may influence the inclination to seek out sexual contact 
with a partner. This outcome further indicates that individuals experiencing moderate 
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levels of negative affect did not have reduced frequency of sexual experiences compared to 
those with no anxiety and depression symptoms. This lends itself to the hypothesis that 
individuals experiencing symptoms of anxiety and/or depression may experience no 
change or potentially increased sexual libido (sees also Bancroft et al, 2004; Ware et al., 
1996).  
 It is acknowledged that this pattern is only evident for one measure of SRT in this study 
(i.e. number of one-night stands with different partners within the lifetime); however, this 
may simply be an artefact of the type of linear analysis that was undertaken. Indeed, 
Crepaz and Marks (2001) recommend the use of curvilinear analysis to assess the inverted 
U hypothesis of the association between SRT and negative affect. Despite this researchers 
have asserted that the findings of Crepaz and Marks (2001) may actually be the result of 
the failure of earlier studies to account for various moderator variables (Janssen & 
Bancroft, 2006). Moreover, this research has continued to adopt linear statistical models in 
the analysis of the relationship between negative affect and SRT. Thus, two lines of future 
enquiry should consider curvilinear forms of analysis as well as the role of moderator 
variables in order to explore the hypotheses proposed, and further develop the 
understanding of the association between negative affect and SRT. 
 
Relationship Between Negative Affect and Impulsivity 
In support of the hypothesis that individuals with anxiety and depressive symptoms would 
exhibit increased levels of impulsivity, the correlational analysis highlighted significant 
positive associations with the composite impulsivity score and three of the five factors of 
impulsivity. This translates to a tendency to act rashly in both negative and positive 
emotional contexts (i.e. negative and positive urgency) for individuals with higher levels of 
anxiety and depression, and a propensity to not think through potential consequences of 
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one’s actions (i.e. premeditation factor) during higher levels of anxiety only. There was an 
association between the composite score of impulsivity and depression only. 
 In the group comparison analysis the same three factors of impulsivity and composite 
score were also significant. For depressive symptoms the impulsivity composite score was 
found to be significant between non-depressed and depressed individuals, indicating a 
clear distinction on the low and high points of a broad impulsivity continuum. For 
individuals classified as both anxious and depressed there was increased tendency to act 
rashly in negative emotional contexts (i.e. negative urgency). These outcomes may be best 
explained by an escape strategy whereby individuals experiencing anxiety/depressive 
symptoms often take immediate action, by engaging in avoidance behaviour, to escape 
anxiety provoking or low-mood triggering stimuli. In the context of SRT, one could 
hypothesise that engaging in sexual practices, including SRT, serves as a function to avoid 
triggers of unpleasant symptomatology associated with anxiety and depression.  
 A similar pattern of group comparisons were found for a tendency to act rashly during 
positive emotional states (i.e. positive urgency) for both anxious and depressed individuals. 
It may be that when anxious or depressed individuals engage in actions to capitalise upon 
the enjoyment and pleasurable effects of positive affect whilst it is experienced. Thus, rash 
action following positive emotional states may serve as a function to avoid re-entering a 
negative mood state.  
 Finally, there was a significant difference found between the non-anxious and anxious 
groups for a tendency not to think through consequences of one’s behaviour (i.e. 
premeditation factor). This factor is an indicator of low self-control (Latzman & Vaidya, 
2013), and the findings here may reflect the impact that anxiety disorders can have upon 
cognitive processing including risk appraisal and problem solving deficits, which can 
impair self-directed positive and protective behaviour (Canin et al. 1999).  
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Relationship Between Sexual Risk-Taking, and Mood-Related Sexual Desire and 
Impulsivity  
Positive associations were found between anxiety-related sexual desire and three SRT 
measures: number of different sexual partners in the past 12 months; one night stands in 
the lifetime; and unprotected sex in the past 12 months. Although no significant 
correlations were found for depression-related sexual desire, comparing groups indicated 
significance with number of different sexual partners in the past 12 months. Taken in 
conjunction this outcome supports the hypothesis that individuals who experience 
increased MRSD during negative affective states, engage in sex with multiple partners.  
 In addition, it was found that individuals with elevated sexual-desire when anxious were 
more likely to engage in unprotected sex. This may be explained by the experience of 
anxiety symptoms prior to engaging in the process of social interaction needed to negotiate 
condom use with a partner (Brooks-Gunn & Paikoff, 1997). Indeed, individuals with 
anxiety disorder may experience heightened levels of negative arousal following condom 
negotiation with a partner leading to loss of erection, which may mediate attempts at safe 
sex (e.g. Bancroft et al., 2003). The differences in findings pertaining to MRSD when 
anxious or when depressed may be accounted for by additional factors not explored here 
(e.g. relationship status) or methodological considerations such as the limited variation 
across depressed groups, with the majority of participants classified as non-depressed. 
Future research could investigate these associations through employing greater sample 
sizes and more sophisticated forms of statistical analysis such as regression analyses. 
 A tendency to act rashly following negative (negative urgency) and positive emotional 
contexts (positive urgency), as well as difficulties with thinking through consequences to 
actions (premeditation factor) were found to be significantly associated to MRSD when 
anxious. A similar finding was observed with MRSD when depressed, where there was a 
tendency to act rashly following negative (negative urgency) and positive (positive 
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urgency) emotional states, although the composite impulsivity score was significant. In this 
instance it may be logical to hypothesise that at a simplistic level, anxious and depressive 
symptoms trigger a desire to escape from unpleasant negative affect (i.e. negative urgency) 
and desire to avoid re-entering a negative affective state when experiencing positive 
emotion (i.e. positive urgency), thereby precipitating action toward sex for the purpose of 
‘self-medication’.  
 
Study Strengths and Limitations, and Future Directions 
The results of this study extend extant findings on the relationship between negative affect 
and SRT, including a consideration of impulsivity and MRSD. As far is the author is 
aware, it is the first time these relationships have been explored collectively. Thus, while 
there are a number of strengths of the study, it is acknowledged that there are a number of 
limitations, which present avenues for future research.  
 First, the study included the use of specialised measures developed from the latest 
theoretical and empirical findings pertaining to impulsivity and MRSD (Cyders et al., 
2014; Janssen et al., 2013), and is of the first to use these measures in a research context. 
In particular, the use of the 5-factor impulsivity measure has further highlighted the 
importance of accounting for the multi-dimensional nature of this personality construct 
(Birthrong & Latzman, 2014), beyond the focus of single facets (e.g. sensation-seeking). 
Furthermore, the variability in MRSD experienced by depressed and anxious individuals 
highlighted the influence of various impulsivity characteristics. However, there are a 
number of other potentially important variables that have been identified as moderating the 
association between negative affect and SRT (Janssen & Bancroft, 2006) that warrant 
further empirical study in order to better understand the nature of the association. For 
instance, the Dual Control model developed by the Kinsey Institutes suggests that the 
interactive processes of inhibition and excitation may offer a fruitful area for future 
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exploration (Janssen & Bancroft, 2006). These two constructs are multi-dimensional and 
incorporate considerations of MRSD and impulsivity, so would present a logical next step 
following from the current study.  Moreover, an important consideration, which has not 
been evaluated in this study, is the potential influence of anti-depressant/anxiety 
medications on SRT outcomes. Selective serotonin-reuptake inhibitors (SSRIs) and beta-
blockers for instance, can affect a person’s subjective desire/interest to engage in sex, their 
physiological arousal (e.g. ability to obtain/maintain an erection), and their sexual 
performance (e.g. ability to achieve orgasm) (Clayton et al., 2002). Participants in this 
study were not asked to report on whether they had received a formal diagnosis and if they 
were taking prescribed medications. It is possible that participants may have experienced 
libido-suppressing effects of anti-depressant/anxiety medications, which may have altered 
their typical pattern of sexual practices and potential for engagement in SRT behaviours. 
This important issue should be considered in future research.  
 Secondly, a degree of caution is required when interpreting the findings of the study, as 
specific aspects of the design may be prone to risk of bias. For instance, it was not always 
possible to undertake the planned analysis to explore differences between groups. The 
most notable instance was for the depressed groups where there were insufficient numbers 
of people (n=3) classified as symptomatic according to the recognised cut-offs (score >11; 
Zigmond & Snaith, 1983). At the risk of the loss of variability (by reducing the number of 
groups from three to two), in order to maximise statistical power an alternative 
categorisation was used according to a cut off of >8, which has been validated for use in 
primary care (e.g. Wilkinson & Barczak, 1988) and out-patient samples (e.g. Olsson, 
Mykletun, & Dahl, 2005). This is a particular limitation of utilising a convenience sample, 
whereby the study is dependent upon those whom are inclined to participate. This is 
associated with increased risk of participation bias whereby certain types of individuals 
will choose to participate while others will not. 
  77 
 Thirdly, the timing and location of completion of the survey may have influenced 
responses. For example, it is possible that participants who completed the survey in the 
clinic waiting room may have experienced elevated situational anxiety compared to 
participants who chose to complete at home. Additionally, participants who completed the 
survey prior to their clinic appointment may have experienced anticipatory anxiety; 
alternatively those whom completed after their appointment may have experienced anxiety 
and/or low mood in response to knowledge acquired about a health or treatment outcome. 
These factors may have introduced a degree of bias to the data, but were not accounted for 
in the analysis. 
 Fourthly, the demographics of the sample demonstrate bias toward white, female, young 
adults. While it wasn't the intention to recruit a specific sample, which has been the case in 
many of the studies exploring the effect of negative affect on sexuality within specific risk 
groups (i.e. homosexual males, see Bancroft et al., 2003, 2004; drug-users, see Marks et 
al., 1998), when taken in isolation the findings lack generalizability. However, given that 
there is beginning to amass a number of studies supporting the "paradoxical relationship” 
between negative affect and sexuality in a variety of different cohorts, taking the evidence-
base as a whole suggests that the finding might be generalizable beyond the specific study 
samples. Nonetheless, future research would benefit from a more purposive sampling 
strategy that would overcome the risk of participation bias, enabling the appropriate 
analyses to be undertaken, and increasing the generalizability of the findings to the wider 
population. 
 In addition, studies in the field of negative affect and SRT have tended to employ cross-
sectional designs. While such designs are appropriate during the initial exploratory stages 
of a field, as they require relatively little resources and are not very labour intensive, they 
are limited in terms of understanding the causal nature of an association. Thus, it is not 
possible to infer whether the symptoms of anxiety and depression caused the increased 
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SRT, or vice versa. Indeed, both are plausible. This in particular requires further work, as it 
is here that the clinical implications of the association lie in terms of understanding with 
whom and how to intervene. In order to better understand the causal nature of the 
association it would be necessary to consider other epidemiological study designs: initially, 
case-control studies would provide a better understanding before moving on to more 
resource- and labour-intensive prospective, longitudinal studies.  
 Finally, as with all self-report methods, particularly when they require retrospective 
recall, it is necessary to consider the risk of response and recall bias. In particular, the 
extent of one’s anxious and/or depressive symptoms may inhibit an objective assessment 
of SRT, especially when required to recall such behaviours over an extended timeframe 
(i.e. one night stands in a lifetime). Moreover, the way in which constructs were measured 
in this study limits the ability to draw conclusions because of a mismatch between state 
and trait measures over different time periods. The issue of temporal incongruence 
between measures such that, for example the HADS measures state anxiety and depression 
(i.e. over the past 2 weeks) whereas some of the SRT behaviours used were measured over 
longer periods (i.e. 12-months and lifetime). Indeed, the multi-factor impulsivity construct, 
as measured by the SUPPS-P, can be considered a trait measure. Thus, it is not possible to 
associate directly the experience of negative affect or impulsivity factors with the 
occurrence of SRT. In order to address this issue, it would be necessary to use a trait 
measure of anxiety and depression; however, no such scale exists that also accounts for the 
confounding effect of the clinical environment on responses in the same way that HADS 
does (see Zigmond & Snaith, 1983). Thus, until such a measure is devised the issues 
associated with temporal incongruence will continue to blight the evidence base. Although 
it is recommended that the behavioural indicators used to measure SRT be varied across 
different temporal parameters (see Slaymaker, 2004), future investigations should address 
the issue of temporal incongruence to increase study validity. 
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Clinical Implications 
The current findings when considered alongside the wider evidence base suggest that 
individuals experiencing moderate levels of anxiety and depression, and increased desire 
for sex, and impulsivity during these negative affective states, may be more likely to 
engage in SRT behaviours, placing them at increased risk for contracting a STI.  In routine 
clinical practice screening for these factors may enable sexual-health practitioners to 
identify and focus on those at greatest risk. For example, knowing that a patient 
experiences elevated sexual desire and difficulties with impulse control and/or thinking 
through the potential consequences of one’s actions during anxious and/or depressive 
states may support formulation of a patient’s STI risk. This information may guide 
practitioners in their selection and use of appropriately tailored interventions to support 
patients in their awareness of the risks they face. 
 
Conclusion 
Personality factors and mood states can go only part of the way in explaining SRT 
behaviour. As has been illuminated by the findings here, the "paradoxical relationship" 
frequently reported within the literature may be best examined in relation to a dual control 
perspective highlighting the interactive processes of inhibition and excitation. The present 
study has shown that relationships exist between SRT and anxiety, depression, MRSD and 
impulsivity; however it may be time to approach a practice-based evidence approach to 
further support understanding of theoretical development. Thus, both offering guidance 
and support to those at risk, and providing much needed supplementary evidence to feed 
into future theoretical construction. 
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Appendix II. STROBE Statement Checklist 
 
Item. Recommendation Page  
 
Relevant text from 
manuscript 
Title and abstract 1 (a) Indicate the study’s design with a commonly used term in the title or the abstract   
(b) Provide in the abstract an informative and balanced summary of what was done 
and what was found 
  
Introduction  
Background/rationale 2 Explain the scientific background and rationale for the investigation being reported   
Objectives 3 State specific objectives, including any prespecified hypotheses   
Methods  
Study design 4 Present key elements of study design early in the paper   
Setting 5 Describe the setting, locations, and relevant dates, including periods of recruitment, 
exposure, follow-up, and data collection 
  
Participants 6 (a) Cohort study—Give the eligibility criteria, and the sources and methods of 
selection of participants. Describe methods of follow-up 
Case-control study—Give the eligibility criteria, and the sources and methods of case 
ascertainment and control selection. Give the rationale for the choice of cases and 
controls 
Cross-sectional study—Give the eligibility criteria, and the sources and methods of 
selection of participants 
  
(b) Cohort study—For matched studies, give matching criteria and number of 
exposed and unexposed 
Case-control study—For matched studies, give matching criteria and the number of 
controls per case 
  
Variables 7 Clearly define all outcomes, exposures, predictors, potential confounders, and effect 
modifiers. Give diagnostic criteria, if applicable 
  
Data sources/ 
measurement 
8*  For each variable of interest, give sources of data and details of methods of 
assessment (measurement). Describe comparability of assessment methods if there is 
  
  89 
more than one group 
Bias 9 Describe any efforts to address potential sources of bias   
Study size 10 Explain how the study size was arrived at   
 
Quantitative variables 11 Explain how quantitative variables were handled in the analyses. If applicable, describe 
which groupings were chosen and why 
  
Statistical methods 12 (a) Describe all statistical methods, including those used to control for confounding   
(b) Describe any methods used to examine subgroups and interactions   
(c) Explain how missing data were addressed   
(d) Cohort study—If applicable, explain how loss to follow-up was addressed 
Case-control study—If applicable, explain how matching of cases and controls was 
addressed 
Cross-sectional study—If applicable, describe analytical methods taking account of 
sampling strategy 
  
(e) Describe any sensitivity analyses   
Results 
Participants 13* (a) Report numbers of individuals at each stage of study—eg numbers potentially eligible, 
examined for eligibility, confirmed eligible, included in the study, completing follow-up, 
and analysed 
  
(b) Give reasons for non-participation at each stage   
(c) Consider use of a flow diagram   
Descriptive data 14* (a) Give characteristics of study participants (eg demographic, clinical, social) and 
information on exposures and potential confounders 
  
(b) Indicate number of participants with missing data for each variable of interest   
(c) Cohort study—Summarise follow-up time (eg, average and total amount)   
Outcome data 15* Cohort study—Report numbers of outcome events or summary measures over time   
Case-control study—Report numbers in each exposure category, or summary measures of 
exposure 
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Cross-sectional study—Report numbers of outcome events or summary measures   
Main results 16 (a) Give unadjusted estimates and, if applicable, confounder-adjusted estimates and their 
precision (eg, 95% confidence interval). Make clear which confounders were adjusted for 
and why they were included 
  
(b) Report category boundaries when continuous variables were categorized   
(c) If relevant, consider translating estimates of relative risk into absolute risk for a 
meaningful time period 
  
 
Other analyses 17 Report other analyses done—eg analyses of subgroups and interactions, and sensitivity 
analyses 
  
Discussion 
Key results 18 Summarise key results with reference to study objectives   
Limitations 19 Discuss limitations of the study, taking into account sources of potential bias or imprecision. 
Discuss both direction and magnitude of any potential bias 
  
Interpretation 
 
20 Give a cautious overall interpretation of results considering objectives, limitations, 
multiplicity of analyses, results from similar studies, and other relevant evidence 
  
Generalisability 21 Discuss the generalisability (external validity) of the study results   
Other information  
Funding 22 Give the source of funding and the role of the funders for the present study and, if 
applicable, for the original study on which the present article is based 
  
 
*Give information separately for cases and controls in case-control studies and, if applicable, for exposed and unexposed groups in cohort and cross-sectional studies. 
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Appendix IV: Sub-group Category Frequencies 
Participant demographic and HADS score frequencies 
  HADS-A HADS-D 
 Total Asymptomatic Borderline Symptomatic Asymptomatic Symptomatic 
Gender       
Male 41 9 14 18 22 14 
Female 79 24 15 40 62 17 
       
Education 
level 
      
1 13 1 4 8 11 2 
2 21 2 4 15 12 9 
3 44 14 13 17 28 16 
4 42 17 7 18 38 4 
   
Income 
level 
  
1 62 19 11 32 54 8 
2 25 2 8 15 15 10 
3 14 5 5 4 10 4 
4 8 3 3 2 3 5 
5 9 3 1 5 5 4 
6 2 2 0 1 1 0 
       
Age 
1 21 6 4 11 19 2 
2 57 17 11 29 51 6 
3 24 11 5 8 11 13 
4 12 1 7 4 6 6 
5 6 1 2 3 1 5 
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Participant demographic and SUPPS-P total score frequencies 
 SUPPS-P total 
 Total None Low Moderate/High 
Gender     
Male 41 6 15 20 
Female 79 15 45 19 
     
Education 
level 
    
1 12 4 3 6 
2 21 4 7 10 
3 44 5 30 9 
4 42 8 20 14 
     
Income 
level 
    
1 62 8 34 20 
2 25 5 8 12 
3 14 4 9 1 
4 8 2 3 3 
5 9 1 5 3 
6 2 1 1 0 
     
Age     
1 21 2 7 12 
2 57 8 38 11 
3 24 4 9 11 
4 12 6 4 2 
5 6 1 2 3 
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Participant demographic and negative urgency score frequencies 
 SUPPS-P negative urgency 
 Total None Low Moderate High 
Gender      
Male 41 6 10 17 8 
Female 79 15 23 26 15 
 
Education 
level 
1 12 0 4 6 2 
2 21 1 2 10 8 
3 44 5 15 18 6 
4 42 15 12 9 6 
 
Income 
level 
1 62 12 17 20 13 
2 25 4 8 8 5 
3 14 4 3 6 1 
4 8 0 0 6 2 
5 9 0 5 3 1 
6 2 1 0 0 1 
 
Age 
1 21 5 6 7 3 
2 57 8 19 19 11 
3 24 5 4 9 6 
4 12 2 4 4 2 
5 6 1 0 4 1 
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Participant demographic and perseveration score frequencies 
 SUPPS-P perseveration 
 Total None Low Moderate/High 
Gender     
Male 41 17 11 13 
Female 79 33 37 9 
 
Education 
level 
1 12 5 5 2 
2 21 9 7 5 
3 44 19 16 9 
4 42 16 20 6 
 
Income 
level 
1 62 23 30 9 
2 25 12 8 5 
3 14 7 4 3 
4 8 5 1 2 
5 9 3 3 3 
6 2 0 2 0 
 
Age 
    
1 21 6 8 7 
2 57 24 28 5 
3 24 11 7 6 
4 12 6 4 2 
5 6 3 1 2 
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Participant demographic and premeditation score frequencies 
 
 
 
 
 
  
 SUPPS-P premeditation 
 Total None Low Moderate/High 
Gender     
Male 41 17 9 15 
Female 79 22 40 17 
 
Education 
level 
1 12 4 4 4 
2 21 6 9 6 
3 44 20 18 6 
4 42 9 18 15 
 
Income 
level 
1 62 16 29 17 
2 25 6 11 8 
3 14 9 4 1 
4 8 5 0 3 
5 9 2 4 3 
6 2 1 1 0 
 
Age 
1 21 1 9 11 
2 57 22 23 12 
3 24 7 11 6 
4 12 5 6 1 
5 6 4 0 2 
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Participant demographic and sensation seeking score frequencies 
 SUPPS-P sensation-seeking 
 Total None Low Moderate High 
Gender      
Male 41 0 6 20 15 
Female 79 13 11 36 19 
 
Education 
level 
1 12 0 3 6 3 
2 21 7 2 8 4 
3 44 4 5 22 13 
4 42 2 7 19 14 
 
Income 
level 
1 62 8 8 23 23 
2 25 0 4 17 4 
3 14 4 3 6 1 
4 8 0 0 6 2 
5 9 0 2 3 4 
6 2 1 0 1 0 
 
Age 
1 21 2 0 9 10 
2 57 5 10 25 17 
3 24 4 2 13 5 
4 12 2 5 4 1 
5 6 0 0 5 1 
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Participant demographic and positive urgency score frequencies 
  
 Total None Low Moderate High 
Gender      
Male 41 11 11 14 5 
Female 79 33 29 8 9 
 
Education 
level 
1 12 3 6 3 1 
2 21 7 1 4 9 
3 44 15 16 12 1 
4 42 19 17 3 3 
 
Income 
level 
1 62 20 26 9 7 
2 25 10 3 5 7 
3 14 7 6 1 0 
4 8 2 2 4 0 
5 9 4 2 3 0 
6 2 1 1 0 0 
 
Age 
1 21 6 7 4 4 
2 57 24 22 6 5 
3 24 6 6 7 5 
4 12 7 3 2 0 
5 6 1 2 3 0 
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Abstract 
Background: Depression and/or anxiety can contribute to sexual risk-taking behaviour. 
This is associated with unintended pregnancies and sexually transmitted infection, which 
constitute a significant public health concern. Sexual risk-taking may result from an 
association between depression and/or anxiety symptoms and impulsivity. In addition, 
there is evidence to suggest that depression and/or anxiety symptoms may increase sexual 
activity for some individuals as a means to regulate mood. To the best of the author’s 
knowledge, there has been no study examining the relationship between depression and/or 
anxiety symptoms and how this relates to sexual risk-taking behaviour, impulsivity and 
sexual interest. 
Aims: The aims of this study are to: 1. explore the association that depression and/or 
anxiety symptoms have with sexual risk-taking, sexual interest and impulsive behaviours, 
and 2. Investigate how these factors relate to various participant socio-demographic 
variables. 
Methods: Individuals aged 16 years and over, attending an inner-city sexual health clinic, 
will be asked to anonymously complete a survey booklet containing questionnaires 
measuring depression and/or anxiety symptoms, impulsivity and sexual interest during 
negative mood states. Completion will be paper-based whilst in the waiting room, at home 
or electronically using an internet link. 
Applications: Effective screening of depression and/or anxiety symptoms within sexual 
health clinic settings may provide an opportunity for assessment and intervention for both 
mental health difficulties and sexual risk-taking behaviour. 
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Introduction 
Depression and/or anxiety symptoms can contribute to sexual risk-taking behaviour.
1,2,3
   
For instance, a prospective study in the U.S explored the relationship between depression, 
sexual risk-taking behaviour and sexually transmitted infection (STI) by home-
interviewing a cohort of white and black young adults.
2
 It found that when controlling for 
demographic, socioeconomic, adolescent STI risk, and substance use variables, the 
association between depression and sexual risk-taking behaviour remained. This suggests 
that depression may influence STI risk independently of these other important factors. 
They further highlighted that gender and ethnicity-specific dimensions mediate a strong 
link between depression and STI risk. They highlighted the need to step up integration of 
mental and sexual health screening and prevention programmes for young adults amongst 
the general public especially those of black ethnicity.  The link between anxiety and sexual 
risk-taking is somewhat more tentative, with limited evidence suggesting that individuals 
with anxiety disorders may be more likely to report STIs and engage in increased sexual 
risk-taking.
4,5
 
 It has been proposed that sexual risk-taking behaviour encompasses a range of sexual 
practices such as, condom non-use and multiple sexual partners which are associated with 
unintended pregnancies and STI,
6
 including Human Immunodeficiency-Virus (HIV) 
infection.
7
 It would, therefore seem that both screening and diagnosis for anxiety and 
depression are necessary not only because these conditions constitute a significant public 
health concern in themselves but also because addressing anxiety and depression may lead 
to improved physical health, including reduced risk for STI. 
 Sexual risk-taking behaviour may be due to an association between depression and/or 
anxiety symptoms and the trait construct of impulsivity.
8
 Research indicates that 
individuals identified as anxious can be higher on impulsivity scores than individuals who 
are not anxious.
9
 Similarly, there is evidence to suggest that depressed individuals can rate 
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higher on levels of impulsivity than non-depressed individuals.
10,11
 Furthermore, there is 
evidence to suggest impulsivity may underlie other risk-taking behaviours, including drug 
misuse, physical violence in addition to sexual risk-taking behaviour.
12,13
  Historically, the 
construct of impulsivity has received numerous inconsistent conceptualisations within the 
literature resulting in the development of a host of measurements.
14,15
 This has resulted in 
varying outcomes when researchers have investigated the link between impulsivity and 
risk-taking behaviour.
16
 Confirmatory factor analysis has indicated that impulsivity 
encompasses five distinct facets with the inclusion of sensation seeking, lack of 
premeditation, lack of perseverance, and both negative and positive urgency.
14,17
 In 
particular, sensation seeking and sexual risk taking appear to be strongly associated and it 
is therefore important to include an impulsivity measure which can capture this facet in 
research studies (e.g. The Short English Version of the UPPS-P Impulsive Behavior Scale 
[SUPPS-P].
14 
 
The link between depression and/or anxiety symptoms and sexual risk-taking behaviour 
may be mediated by increased sexual interest during depressive and/or anxious mood 
states, for the purpose of mood regulation, need for intimacy and self-validation.
18,19
 
Research has tended to find that depression
20, 21
 and anxiety symptoms 
22, 23,24
 reduced 
sexual desire and response. However, a body of evidence indicates that sexual desire and 
response may actually increase for some individuals when depressed 
18, 25, 26,
 and 
anxious.
27,28
 For instance, in a study with men who have sex with men (MSM), sexual 
activation (i.e. appetitive sexual affect) increased sexual risk-taking, whereas on days when 
higher levels of positive mood ensued there was an associated decrease in STI/HIV risk-
taking behaviour (i.e. non-use of condoms).
4 
 
This suggests that there are individual differences in the impact of mood on sexual 
interest and sexual risk taking, with depression and/or anxiety symptoms mediating a 
reduction in sexual interest for some, but no change or increased interest for others. 
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Recently, a study found that when using the Revised Mood and Sexuality Questionnaire 
(MSQ-R) heterosexual women were less likely than heterosexual and homosexual men to 
experience increased sexual desire when anxious.
29
 Also, homosexual men and 
heterosexual women were less likely to experience increased desire when depressed.
29
 This 
further highlights the intricate variability in individual differences between mood and 
sexual interest. 
 Depression and/or anxiety symptoms, impulsivity and risk-taking behaviour have been 
shown to co-occur with multiple psychological disorders such as personality disorder, 
eating disorder, addictions and bipolar-affective disorder.
30
 Consequently, a simple, yet 
effective strategy of routinely screening for depression and anxiety symptoms within 
sexual health clinical settings may provide a significant opportunity to target this 
population group for assessment and intervention to address both mood problems and 
sexual risk-taking behaviour. In addition, identifying the individual variability in mood, 
sexual interest, impulsivity and behavioural response may play a role in determining which 
kind of media-based message will be most effective in public health promotion 
campaigns.
31 
 
There is little research evaluating outcomes of negative mood states, impulsivity and 
sexual interest on sexual risk-taking behaviour. Previous studies of clinical and non-
clinical population samples have focused on specific sub-groups, including: specific ethnic 
groups,
3
 adolescents only,
32
 men or women only,
18
 heterosexuals or homosexuals only,
8
 
and most studies, to some degree, have concentrated on substance use.
33
 The interplay 
between a broader clinical sample with a range of ages, ethnic groups, sexual orientations 
and genders with depression and/or anxiety symptoms, impulsivity and sexual interest has 
not been considered, as far as the author is aware.  As a result of these limitations the 
existing findings are limited in terms of informing clinical practice and public health 
policy. 
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 This study is exploratory in nature and seeks to address gaps in the evidence base 
relating to depression and anxiety with sexual risk-taking, sexual interest and impulsivity 
within a clinical group sample. 
 
Aims and Hypotheses 
Aims 
This research project aims to explore the association that: 
 
1. Depression and/or anxiety symptoms have with sexual risk-taking and impulsive 
behaviours among patients attending an inner-city sexual health clinic.  
 
2. Socio-demographic factors (age; gender; ethnicity; sexual orientation; marital status; 
socio-economic status; employment status; and educational attainment) have with 
depression and/or anxiety symptoms, sexual risk-taking and impulsive behaviours.  
 
Hypotheses 
Hypothesis 1a: Individuals with depression symptoms will exhibit increased levels of 
sexual risk-taking behaviour compared to non-depressed individuals. 
 
Hypothesis 1b: Individuals with depression symptoms will exhibit increased levels of 
impulsive behaviour compared to non-depressed individuals. 
 
Hypothesis 1c: Individuals with depression symptoms who rate highly on sexual interest 
will exhibit higher levels of sexual risk-taking and impulsivity than individuals with 
depression symptoms who rate low on sexual interest when depressed. 
 
Hypothesis 2a: Individuals with anxiety symptoms will exhibit increased levels of sexual 
risk-taking behaviour compared to non-anxious individuals. 
 
Hypothesis 2b: Individuals with anxiety symptoms will exhibit increased levels of 
impulsive behaviour compared to non-anxious individuals. 
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Hypothesis 2c: Individuals with anxiety symptoms who rate highly on sexual interest will 
exhibit higher levels of sexual risk-taking and impulsivity than individuals with anxiety 
symptoms who rate low on sexual interest when anxious. 
 
Plan of Investigation 
Participants  
All individuals attending an inner-city sexual health clinic (i.e. Sandyford Central), 
situated within NHS Greater Glasgow and Clyde (NHSGGC) in Glasgow will be invited to 
participate. Criteria for participation include: 
 
Inclusion Criteria 
 All individuals attending Sandyford Central Sexual Health Clinic  
 All students of the University of Glasgow (only in the event that participation 
numbers are below predicted requirements for adequate power from Sandyford 
Central) 
 
Exclusion Criteria  
 Inability to read/understand English language  
 Visual impairment that would compromise an individual’s ability to view/read the 
research material 
 Inability to provide implied consent e.g. an individual with a defined learning 
disability as qualified by DSM-V. 
 Below age 16 years 
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Recruitment Procedures  
Primary recruitment method 
Attendees to an inner-city sexual health clinic will be requested to anonymously complete 
a survey booklet containing four brief questionnaires.  
 Sandyford is the largest integrated sexual, reproductive, and emotional health service 
within Scotland. The clinic is staffed with a range of specialist medical consultants, 
advanced nurse practitioners and psychotherapists, and offers a range of services. 
Individuals wishing to seek the services of Sandyford make contact with the clinic 
receptionist following walk-in or scheduled appointment to register their attendance for 
appointment. Following standard procedure the clinic receptionist will book the patient in, 
confirming their appointment with the relevant health professional. They will then be 
offered a Participant Information Sheet (PIS) so that they may make an informed decision 
to take part in this research study requiring anonymous completion of a brief survey 
booklet while they wait to be called for their appointment. The PIS will detail the aims of 
the study, their required involvement and how they can proceed with taking part. Due to 
the anonymous nature of this study, participation will require implied consent. The PIS and 
the eligibility screening form at the beginning of the survey booklet will explain that 
participants do not have to provide personal information or a signature to offer consent, but 
rather, completion of the survey booklet will provide implied consent. To confirm 
understanding of implied consent each participant will be required to mark a tick box, 
which must be completed should they wish to participate.   Patients will be informed that 
they can opt out of the study at any time without reason, but given the anonymous nature 
of the survey, their data will not be able to be removed at a later date. 
 Attendees to the clinic will be informed by the receptionist the location where the 
survey booklets will be situated (e.g. on a table next to the reception, easily accessible to 
clinic attendees). All clients will be provided with the main researcher’s email address and 
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telephone number, included in the survey booklet in the event they wish to ask any 
questions pertaining to the study and participation. If the client’s wait time is 15 minutes or 
longer participants will be encouraged to complete the questionnaire on site prior to 
appointment. If the wait time is less than 15 minutes, or the client does not wish to 
complete the questionnaire prior to their appointment three options will be available for all 
to choose from if they wish to take part (1) completion of questionnaire after their 
appointment on site (2) completion of questionnaire off site, which can be returned using a 
free postal addressed envelope enclosed or (3) if they have access to the internet they can 
go online to complete the survey booklet by copying and following a link on the PIS 
(Please see Figure 1 to view participant recruitment pathway). 
 Participants who complete the survey booklet on site will be asked to place them in an 
attached envelope and into sealed boxes located close to reception in the clinic waiting 
area.  
 Participation in the study will not affect subsequent care or treatment (e.g. sexual health 
assessment or review). Individuals not eligible for participation or those who choose not to 
participate will receive routine care and treatment. Likewise, those who complete the 
survey booklet will be seen by the relevant health professional as per routine clinic 
protocol for their visit.  
 
Secondary Recruitment Method 
As a contingency, in the event that response rate in the primary recruitment site is low, a 
secondary recruitment method will be used. This would involve seeking participants from 
the University of Glasgow student population. This would require advertising for voluntary 
participation via posters, email and media networking websites, for completion of the 
survey booklet by internet web link. 
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Figure 1. Flow chart illustrating participant recruitment process 
 
Measures  
Each participant will be given a small survey booklet containing an eligibility-screening 
sheet and four self-report questionnaires.  
(1) Eligibility screening sheet: Completion time approximately 1-2 minutes. Questions 
will include 4 items based upon the exclusion criteria and will require participants 
to circle a yes/no response. Those who respond with a ‘yes’ indicating that they fall 
under the exclusion criteria will be thanked for their time and informed that they 
will be unable to proceed to full participation. Participants will also be required to 
confirm that they understand informed consent is implied when they complete the 
survey booklet. This will require each participant to mark a tick box at the bottom 
of the eligibility sheet. 
(2) Demographic and sexual information questionnaire.  Completion time 
approximately 2-3 minutes. This questionnaire will seek to capture a range of 
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demographic and historical data including age, gender, ethnicity, education level, 
employment status, sexual orientation, relationship status; sexual partner number in 
last year; single occasion sexual contact partners in lifetime; and number of sexual 
partners with whom safe-sex was not practiced.  
(3) Hospital Anxiety and Depression Scale (HADS)34 Completion time approximately 
2-3 minutes. HADS is a commonly used 14-item self-administered assessment 
measure which screens for symptom severity and caseness of anxiety disorders and 
depression in somatic, psychiatric and primary care patients and in the general 
population. It was designed for the purpose of detecting state-level depression, 
anxiety and emotional distress in patients undergoing clinical treatment and 
therefore reduces interference of possible confounding somatic symptoms 
associated with physical health conditions e.g. fatigue. It is not intended for use as a 
clinically diagnostic tool. Patients are asked to complete 14 questions (7 from the 
anxiety and 7 from the depression subscale) with four response options ranging 
from ‘not at all’ to ‘most of the time’. A point is allocated for each answer which 
can be totalled to provide an anxiety score, a depression score and an overall 
emotional distress score. The measure yields good reliability and validity (e.g. 
correlations between the subscales that varies from .40 to.74 (mean.56) and 
Cronbach's alpha for HADS-A varies from .68 to.93 (mean .83) and for HADS-D 
from .67 to.90 (mean.82).   
(4) Short English version of the UPPS-P Impulsive Behaviour Scale (SUPPS-P)14 
Completion time approximately 3-4 minutes. The SUPPS-P is a 20-item self-report 
measure that assesses five subscales (Sensation Seeking, Lack of Perseverance, 
Lack of Premeditation, Negative Urgency, and Positive Urgency) which are used to 
measure five distinct personality dimensions of impulsive behaviour in adults and 
adolescents. It is designed to measure impulsivity across the dimensions of the Four 
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Factor Model of Personality: Premeditation (lack of), Urgency, Sensation Seeking, 
Perseverance (lack of).
35
 The subscales have criterion related associations with 
risk-taking behaviours including binge eating, gambling, drug and alcohol use and 
sexual risk-taking. Each item on the SUPPS-P is rated on a 4-point scale ranging 
from ‘strongly agree’ to ‘strongly disagree’ with a point allocation for each answer 
which can be totalled to form a subscale score (i.e. sensation seeking and an overall 
impulsivity score). Each subscale on the short version (SUPPS-P) has adequate 
reliability - similar compared to long version (UPPS-P).
14
 The SUPPS-P inter-
correlations were generally comparable to the UPPS-P version inter-correlations. 
The SUPPS-P generally replicated the internal consistency (0.74-0.88 across 
subscales) and inter-scale correlations of the original UPPS-P.  
(5) Revised Mood and Sexuality Questionnaire (MSQ-R).29  
Completion time approximately 5 minutes. The MSQ-R is a self-report trait 
measure that asks respondents to indicate what typically happens to their sexual 
interest and response when in a particular mood. It was designed to identify how 
moods influence sexual desire and arousal, sexual behaviour and the reciprocal 
effects of sexual activity on mood (e.g. the effect of anxiety/stress, 
sadness/depression, and happiness/cheerfulness on overall sexual desire, arousal, 
masturbation frequency, and sexual behaviours that may be later regretted). The 
internal consistency of the subscales has been found to be sufficiently high
29
 with 
eight subscales, of which six (21-items in total) will be used in this study. 
 
Design  
This study will employ a cross-sectional design to explore the association between 
symptoms of depression and/or anxiety, sexual interest, sexual risk-taking behaviour and 
impulsivity within a sexual health clinic population sample. 
  112 
Research Procedures  
Participants will be recruited from Sandyford Central (see recruitment section). Each 
survey booklet will contain the main researcher's contact information to allow participants 
to ask questions about the study and self-help material for common mental health 
difficulties which participants can take home with them and use if required. Participants 
will also be given contact details for NHS24 and self-help organisations (e.g. The 
Samaritans and SAMH).  
 The survey booklets will be collected by the researcher bi-weekly over the 8-week 
recruitment phase.  
 
Data Analysis  
Correlational analysis will be conducted to determine the associations between variables. 
A post-hoc analysis using Bonferoni adjustment will be used to correct the p-value to 
reduce the likelihood of type 1 errors due to multiple comparisons. Between groups 
comparisons (e.g. t-tests) will be used to compare those who score above clinical cut-offs 
for depression and anxiety respectively, with those who did not, on the variables being 
analysed. 
 
Justification of sample size  
This study is an explorative study, and to the author’s knowledge no similar study exists in 
the examination of depression and/or anxiety symptoms, sexual interest, impulsivity and 
sexual risk-taking. It is therefore not possible to estimate effect size.  The results of this 
study will be used to generate effect sizes that will facilitate sample size estimate for future 
research. However assuming that anxiety or depression had a correlation with sexual risk-
taking (r = 0.4) the following sample sizes would be required (assuming alpha of 0.025 to 
account for multiple comparisons) with the following power values. 
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Table 1. Power and effect size calculation obtained using G*Power 3.
36 
Power 0.60 0.65 0.70 0.75 0.80 0.85 0.90 
Sample size 52 58 65 73 82 93 109 
 
It is the author’s aim to recruit as many participants as possible within the 8-week 
recruitment phase between September and October 2014.  Sandyford Central was visited 
by 7334 attendees during this time-frame in 2013.
37
 Less than 1% of this figure will be 
required to achieve a sample size necessary to yield a moderate effect. 
 
Settings and Equipment 
Survey booklet completion will be undertaken within two sites, the first being an NHS 
setting, in an open-plan waiting area. The second setting will be dependent upon where the 
participant chooses to complete the survey booklet off site or has access to the internet 
(e.g. in the participant’s home), as the survey booklet will also be accessible for 
completion and submission online. This is to enable increased access to the study and 
facilitate good response rates. Home visits will not be undertaken at any time and the 
researcher and participant will not be in an isolated environment. 
 
Screening measures and questionnaires 
Two of the questionnaires (SUPP-S and MSQ-R) being used in this study are accessible 
only on request of the authors and publishers. The main researcher has received written 
permissions from the authors and authorised use has been granted for the purpose of this 
research project. One other measure being used is within the public domain (e.g. HADS) 
and use is permitted for research purposes. All other stationary materials will be purchased. 
Computer device (laptop) 
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All data obtained from the survey booklets will be transferred onto an NHS encrypted 
laptop computer obtained from the Institute of Health and Wellbeing, Doctorate in Clinical 
Psychology Programme.  
 
Health and Safety Issues 
Researcher Safety Issues  
It is expected that there will be low levels of risk to the researcher. The researcher will 
have no face-to-face contact with participants. 
 
Participant Safety Issues 
Due to the intimate nature of some of the questions being asked, it is possible that 
participants may experience a degree of distress from completing the survey booklet. 
Participants will be informed via the PIS prior to taking part, that questions which will 
require self-reflection on their current mental health status and sexual history. All 
participants will be provided with self-help material including contact details of supportive 
organisations (e.g. Samaritans, SAMH etc.), NHS-24, and useful information on how to 
obtain 1-to-1 support from the Sandyford Listening Ears Counselling Service. Participants 
will be encouraged to make contact with their G.P with any issues of concern, anxieties or 
worries surrounding their physical or mental health which may have arisen following their 
participation in the study. 
 Participants will be reminded of their choice to opt out of completing the survey booklet 
at any time and measures will be taken at all times to ensure participant comfort and safety. 
 
Ethical Issues  
All questionnaires will be completed anonymously and participants will be reminded that 
any information provided by them will not contain any personal identifiers. As such, 
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participant understanding of implied informed consent will be sought via tick-box 
confirmation on the eligibility screening form.  
 Ethical approval for the study will be sought from the Institute of Health and Well-
being Ethical Review Committee and via an application to the National Research Ethics 
Service, via the Integrated Research Application System.  
 
Timetable  
Ethical approval will be sought August-September 2014. Study set up will follow late 
September 2014, with recruitment ongoing from early October 2014. Survey completion 
will run from October-November 2014 and analyses undertaken by late November/early 
December 2014. Write up of the study will continue from December-January 2014 with 
amendments being made in February 2015 for final submission in March 2015. 
 
Practical Applications  
Information about depression and/or anxiety symptoms, impulsivity and sexual interest and 
sexual risk-taking behaviour can be used to identify populations at risk for both depression 
and/or anxiety and health-risk behaviour which may help to inform prevention and 
intervention practices.  
 Symptoms of anxiety and/or depression, and possible associated impulsive behaviours 
should be addressed if interventions to reduce sexual risk-taking behaviour are to be 
improved
18
: 
(1) Given that mood may play a role in sexual interest and impulsivity it offers the 
opportunity to identify those who are not yet engaging in sexual risk-taking 
behaviour who may be at risk of doing so in the future. 
(2) The relationship between mood, sexual interest and impulsivity may illustrate their 
importance in indicating/mediating sexual risk-taking behaviours, and offer 
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effective prognostic utility in forecasting the response outcome (appropriateness to 
fit) of a particular intervention. 
(3) The relationship among mood, sexual interest, impulsivity (i.e. sensation seeking) 
and sexual risk-taking factors may determine which kind of public-health 
promotion campaign is going to be most effective in any intervention mapping 
exercise. One study has demonstrated that high sensation seekers are likely to 
respond to communication styles and practices that would be ineffective or even 
counter-productive in low sensation seekers.
31
 This evidence suggests that using 
more than one message in public-health promotion campaigns may be more 
effective. 
(4) Understanding the interplay between personality factors and mood may provide a 
crucial role in designing appropriate, tailored one-to-one interventions. For 
example, interventions specifically targeting those who are more likely to engage in 
sexual risk-taking when depressed and/or anxious, or who use sex as a form of 
mood regulator. It has been suggested that behavioural analysis of the relationship 
between mood and sexual behaviour (i.e. using a dairy format), can address 
emerging patterns and a focus upon motivation for change, followed by a 
cognitive-behavioural approach to aid in the development and maintenance of 
alternative methods of mood regulation.
18
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Abstract 
‘Evidence-based practice’ and ‘integrated, joined up working’ are two key professional 
principles that I consider to form part of the Clinical Psychology trainee’s mantra. 
Throughout training it is expected that trainee's recognise, adopt, and advocate these 
important working practices, and are encouraged to refer to relevant professional 
guidelines, and reflect upon how these can inform and improve practice. My understanding 
of evidence-based practice and integrated joined-up working arose largely from 
experiential learning during training and, more recently, through wider reading and 
discussion on Existential philosophy in the psychological therapies. Over the course of my 
training I have experienced what I have come to term as ‘doubts of faith’ in how Clinical 
Psychology can enrich an existentialist, medical model-led NHS. This account will 
highlight and reflect upon the various factors that have contributed to my ‘doubts of faith’, 
and how they have shaped my learning, enabled me to develop new insights, and moulded 
my hopes and aspiration for Clinical Psychology within the NHS. I will also discuss the 
philosophical movement termed ‘Post-existentialism’ which has recently gained 
momentum within the profession, and provide a framework to reflect upon my personal 
challenge of balancing the reality of clinical practice and my aspirations toward a 
professional ideology of psychological therapy without foundations (Loewenthal, 2011). 
This has motivated my utilisation of critical and reflective practice to evaluate where I 
(trainee clinical psychologist) and how we (Clinical Psychology profession) operate in 
today’s constrained NHS. 
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Critical Reflection on Learning; the use of a Transformational Learning Model to 
Understand Competency Development in the Context of Supervision 
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Abstract 
The process of learning is a unique venture. It can vary according to mixed experiences 
(e.g. work-related and/or personal), numerous sources of knowledge (e.g. literary or 
individual), and over different time trajectories (i.e. short- v. long-term). I have discovered 
learning is not a linear process for me, but rather an iterative process of self-exploration 
and piecing-together of information over time. Throughout training I have identified that 
my preferred method of learning is in a shared social context, or ‘social-connectivity’ 
(Carroll, 2010b) because I recognise the effectiveness of a learning partnership with others. 
The reciprocal pooling and sharing of resources (e.g. knowledge and experience) has 
enabled me to experience transformational learning through critical reflection. This 
reflective account will discuss the pathways through which my approach to learning has 
developed during D.Clin.Psy. training. Of great significance in this journey was the 
learning acquired during supervision. My experiences from key supervision events will be 
structured around Schon’s (1991) In-On-action model. By integrating Loop- (Argyris & 
Schon, 1972), and Transformational Learning models (Carroll, 2010) I then evaluate each 
stage of my learning to highlight how I have evolved to become a critical reflector through 
a process of transformational learning.  
